Quarterlytics / Consumer Cyclical / Packaging & Containers / Infineon / FY2016 Annual Report

Infineon
Annual Report 2016

IFX · TSX-V Consumer Cyclical
Claim this profile
Ticker IFX
Exchange TSX-V
Sector Consumer Cyclical
Industry Packaging & Containers
Employees 201-500
← All annual reports
FY2016 Annual Report · Infineon
Loading PDF…
ANNUAL REPORT
2016

Committed to Excellence

IN  ALL  SUCCESSFUL  BUSINESSES  THE  KEY  TO  
SUCCESS  RELIES  ON  MANAGEMENT’S  ABILITY  TO  
MASTER THREE FUNDAMENTALS:

> COMMITMENT TO CUSTOMER
> CLEAR VISION OF GOALS
> CORRECT TIMING OF ACTIONS

OUR  SENIOR  MANAGEMENT 
TEAM  KNOWS, 
 UNDERSTANDS  AND  LIVES  BY  THESE  PILLARS  OF 
BUSINESS FUNDAMENTALS.

MANAGEMENT DISCUSSION AND ANALYSIS  

PREFACE 

This  Management  Discussion  and  Analysis  (MD&A)  comments  on  Imaflex  Inc.’s  (the  “Parent  Company”) 
operations,  financial  performance,  financial  condition,  future  outlook  and  other  matters  for  the  three-month 
periods  and  years  ended  December  31,  2016  and  December  31,  2015.    Unless  otherwise  indicated,  the  terms 
“Imaflex”,  “Company”,  “we”,  “our”,  and  “us”  all  refer  to  Imaflex  Inc.,  together  with  its  divisions  Canguard 
Packaging and Canslit, along with its wholly owned subsidiary, Imaflex USA Inc.  All intercompany balances 
and transactions have been eliminated on consolidation. 

This  MD&A  also  provides  information  to  improve  the  reader’s  understanding  of  the  accompanying 
consolidated  financial  statements  and  related  notes.    It  should  be  read  together  with  our  audited  consolidated 
financial statements for the years ended December 31, 2016 and 2015.  

Unless  otherwise  indicated,  all  financial  data  in  this  document  was  prepared  in  accordance  with  International 
Financial Reporting Standards (“IFRS”), as issued by the International Accounting Standards Board (“IASB”) 
and  all  amounts  are  expressed  in  thousands  of  Canadian  dollars.  Differences  may  occur  due  to  rounding  of 
amounts.    We  also  use  financial  measures  that  are  not  defined  by  IFRS.    Please  refer  to  the  section  entitled 
“Non-IFRS Financial Measures” for a complete description of these measures. This MD&A was reviewed by 
Imaflex’s Audit Committee and approved by the Board of Directors on April 18, 2017.  Disclosure contained 
within it is current to that date, unless otherwise indicated.    

Additional  information  on  Imaflex  is  available  on  our  website  at  www.imaflex.com  and  on  SEDAR  at 
www.sedar.com.  

FORWARD LOOKING STATEMENTS 

From  time  to  time,  we  make  forward-looking  statements  within  the  meaning  of  Canadian  Securities  laws, 
including the “safe harbor” provisions of the Securities Act (Ontario).  We may make such statements in this 
document,  in  other  filings  with  Canadian  regulators,  in  reports  to  shareholders  or  in  other  communications.  
These  forward-looking  statements  include,  among  others,  statements  regarding  the  business  and  anticipated 
financial performance of the Company.  The words “may”, “could”, “should”, “would”, “outlook”, “believe”, 
“plan”, “anticipate”, “expect”, “intend”, “objective”, the use of the conditional tense and words and expressions 
of similar nature are intended to identify forward-looking statements. 

By  their  very  nature,  forward-looking  statements  involve  inherent  risks  and  uncertainties,  both  general  and 
specific,  which  give  rise  to  the  possibility  that  predictions,  forecasts,  projections  and  other  forward-looking 
statements  will  not  be  achieved.  We  caution  readers  not  to  place  undue  reliance  on  these  statements,  as  a 
number  of  important  factors  could  cause  our  actual  results  to  differ  materially  from  the  beliefs,  plans, 
objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements.  
These factors include, but are not limited to, the length and severity of an economic downturn, management of 
credit,  market  dynamics,  liquidity,  funding  and  operational  risks;  the  strength  of  the  Canadian  and  U.S. 
economies in which we conduct business; the impact of the movement of the Canadian dollar relative to other 
currencies, particularly the U.S. dollar; the effects of changes in interest rates; the effects of competition in the 
markets  in  which  we  operate;  our  ability  to  successfully  align  our  organization,  resources,  and  processes;  the 
availability  and  price  of  raw  materials;  failure  to  achieve  planned  growth  associated  with  the  U.S.  operations 
and future sales; changes in accounting policies and methods we use to report our financial condition, including 
uncertainties associated with critical accounting assumptions and estimates; operational and infrastructure risks; 
and  other  factors  that  may  affect  future  results  including,  but  not  limited  to,  timely  development  and 
introduction  of  new  products  and  services;  changes  in  tax  laws,  technological  changes,  new  regulations;  the 
possible  impact  on  our  businesses  from  public-health  emergencies,  international  conflicts  and  other 
developments; and our success in anticipating and managing the foregoing risks. 

Fourth Quarter 2016 

1 

 
 
 
 
 
 
   
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

FORWARD LOOKING STATEMENTS (continued) 

We  caution  our  readers  that  the  foregoing  list  of  important  factors  that  may  affect  future  results  is  not 
exhaustive.  When relying on our forward-looking statements to make decisions with respect to the Company, 
investors and others should carefully consider the foregoing factors and other uncertainties and potential events.  
Unless  otherwise  required  by  the  securities  authorities,  we  do  not  undertake  to  update  any  forward-looking 
statement that may be made from time to time by us or on our behalf. The forward-looking statements contained 
herein are based on information available as of April 18, 2017. 

COMPANY OVERVIEW 

Imaflex is focused on the development and manufacturing of innovative solutions for the flexible packaging and 
agriculture markets.  The Company’s flexible packaging products, largely used to protect and preserve, consist 
primarily  of  polyethylene  (plastic)  film  and  bags,  including  garbage  bags,  as  well  as  metalized  film.    Our 
polyethylene  film  is  mainly  sold  to  printers,  known  as  “converters”,  who  process  the  film  into  a  finished 
product  to  meet  their  end-customer  needs.  Our  agriculture  products  are  comprised  of  both  non-metalized  and 
metalized  mulch  films,  including  standard,  compostable  and  barrier  (fumigant)  films,  along  with  next 
generation crop protection and yield enhancement films, including Shine N’ Ripe XL and ADVASEAL® (under 
development).    The  Company  expects  agriculture  sales  to  become  a  much  larger  revenue  contributor  in  the 
coming years.   

Imaflex operates three manufacturing facilities.  Two are located in the province of Québec, including Montréal 
(Imaflex  Inc.)  and  Victoriaville  (Canguard  and  Canslit),  and  one  is  located  in  Thomasville,  North  Carolina, 
USA (Imaflex USA).  The Company also has a warehouse in Thomasville. The four facilities cover a total area 
of  approximately  21,182  square  meters  or  228,000  square  feet.    Imaflex  and  Imaflex  USA  specialize  in  the 
manufacture  and  sale  of  custom-made  polyethylene  films  and  bags.  Canguard  specializes  in  the  manufacture 
and sale of polyethylene garbage bags, while Canslit specializes in the metallization of plastic film.  We believe 
that  our  manufacturing  presence  in  both  Canada  and  the  United  States  provides  a  competitive  advantage  in 
terms of logistics, currency, and manufacturing flexibility. 

The common shares of the Parent Company, Imaflex Inc., are listed on the TSX Venture Exchange under the 
symbol “IFX”.  The Company’s head office is located in Montréal (Québec). 

Shine N’ Ripe XL  
Shine N’ Ripe XL is a long-lasting, heavy-duty, metalized agricultural mulch film specifically designed to fight 
citrus greening, a bacterial disease  spread by the Asian Citrus Psyllid (ACP), an insect that is threatening the 
citrus  industry.    It  causes  deformed  off-flavoured  fruits,  low  yields  and  eventually  tree  death.  Common 
insecticides alone have proven ineffective in managing ACP.   

Shine N’ Ripe XL helps repel insect infestation through solar reflection.  Its unique ability to reflect ultraviolet 
(UV)  light  disorients  insects,  creating  confusion  between  up  and  down.    Not  only  does  the  film  provide  a 
highly-effective  insect  repellent,  it  also  enhances  tree  growth  and  yield,  while  also  controlling  weeds  and 
bringing  water  preservation  benefits.    Shine  N’  Ripe  XL  has  a  unique  ability  to  maintain  high  long-term  UV 
reflectivity for 3 or more years, making it an environmentally-friendly, economically-viable agricultural film for 
the management of citrus greening.   

Shine N’ Ripe XL is currently being commercialized.  During the fourth quarter ended December 31, 2016, the 
Company received its first significant mulch film order for approximately $1.0 million dollars from one of the 
world’s largest citrus growers.   

Fourth Quarter 2016 

2 

 
 
 
 
 
   
   
 
 
  
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

COMPANY OVERVIEW (continued) 

ADVASEAL® Commercialization 
ADVASEAL®  is  a  next  generation,  crop  protection  product  currently  under  development  and  an  important 
growth platform for Imaflex.  The underlying technology is patent protected until 2032 and the Company has 
obtained  or  is  in  the  process  of  filing  for  patent  protection  in  the  top  20  major  vegetable  and  fruit  producing 
countries in the world, including Central-America, the USA and the European Union. 

Most of the plastic mulch used annually worldwide is applied in conjunction with the spraying of herbicides and 
pesticides  or  the  application  of  fumigants.    ADVASEAL®  simplifies  this  process  in  a  safe,  environmentally-
friendly and cost effective way, by allowing for the controlled release of crop protection products (pesticides, 
fungicides and herbicides) using a patent protected mulch film that has been coated with the active ingredients.  
It is safe to handle, transport and apply, and unlike the traditional practice of chemical spraying, there is no need 
for  protective  gear.    It  also  permits  exact  dosing  of  expensive  chemicals,  which  improves  crop  quality  and 
increases yields. 

When the film is used, the ingredients are released in a timely manner only to the soil, eliminating the need for 
costly work steps in the preparation and application of common spray mixtures.  There is also reduced risk of 
toxicity  to  the  crop,  no  wind  drift  of  agrochemicals  into  the  environment  and  no  respiration  hazards  for 
operators or bystanders.    

In addition to being an environmentally-friendly product, management estimates that ADVASEAL® will save 
growers  between  $200  and  $800  per  acre,  depending on  the  crop  grown.    Collectively,  this puts  Imaflex  in  a 
good position to capture market share as ADVASEAL® is commercialized.   

During fiscal 2016, the Company made progress in the process of customizing the coating equipment needed to 
produce ADVASEAL®. The Company is now in the last stages of equipment testing and, once completed, will 
proceed with a field trial of approximately 25 acres,  most of which will be given to selected growers and the 
remainder will be used for lab and US Environmental Protection Agency (EPA) testing.  If the results of this 
testing is positive, the Company will be able to proceed to the process of ordering the equipment. 

MARKET OVERVIEW  

The North American flexible packaging market is valued at approximately US$28 billion. Although this market 
is highly fragmented and commoditized in terms of pricing, there are niches within the larger space that offer 
the opportunity for increased profitability.  In 2016, Imaflex was ranked in the top 100 North American film and 
sheet manufacturers by sales. 

The total addressable global agriculture mulch film market is valued at approximately US$9 billion, for which 
the Company has and continues to develop innovative and proprietary solutions.  In the US alone, the Company 
estimates  that  approximately  130  million  pounds  of  mulch  film  is  being  used,  resulting  in  an  estimated  total 
addressable market of approximately US$750 million. 

Going forward, the Company hopes to capture a much larger share of the agriculture film market due to its next 
generation  crop  protection  and  yield  enhancement  products,  Shine  N’  Ripe  XL  and  ADVASEAL®.    With 
growing concerns over the scarcity of resources, the environment, lower crop yields due to disease, and a rising 
global  population,  the  Company  believes  that  the  macro-environment  is  working  in  its  favour.    Sustainability 
and intelligent farming are becoming increasingly important.      

Fourth Quarter 2016 

3 

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

COMPETITIVE ENVIRONMENT 

Although  competition  is  high  in  all  our  markets,  Imaflex  operates  in  a  multi-billion  dollar  industry  with  a 
multitude of product opportunities.  Flexible packaging alone is used in almost every consumer product market 
to protect and preserve.  Additionally, many of the Company’s customers deal in food related products, which is 
somewhat recession resistant.   

Imaflex believes it has a competitive edge due to its recognition of being an industry leader in the development 
of innovative solutions.  The Company focuses on offering customers unique high quality products on a timely 
basis and at competitive prices.  A key strength of ours is the ability to take on smaller orders with short lead 
times.  Collectively, this helps create customer loyalty.    

Some competitors, experiencing idle operations or producing at below average capacity levels, may attempt to 
gain market share through reduced pricing, particularly during difficult economic times.  Imaflex still believes 
that maintaining its focus on the quality of its products and the excellence of its customer service remains its 
best long-term strategy, as these two characteristics define our position and reputation in the market, and this 
regardless of the fluctuations in the economic cycle.  This strategy has been the backbone of our growth and it 
has served us well.   

We employ a staff of chemical engineers and a chemist, which allows us to develop unique solutions.  In our 
markets,  we  believe  it  is  essential  to  sell  value-added  products  and  avoid  producing  highly  commoditized 
offerings  generating  lower  margins.    The  key  to  this  strategy  is  identifying  and  building  relationships  with 
customers  having  specific  needs  and  eventually  developing  products  that  address  them.  Our  sales  force  is 
mandated to seek out such clients and the Company works to ensure its sales team is technically accomplished 
and equipped to properly communicate the advantages of all products.  

GROWTH STRATEGY 

Management believes the following initiatives will contribute to Imaflex’s long term growth. 

Strengthen the Core  
We will continue to strengthen the core flexible packaging business. This includes revenue growth and margin 
expansion through higher production volumes geared towards the most profitable markets and products, along 
with  a  focus  on  lean  operations  (minimizing  scrap,  reducing  production  set-up  times,  etc.).    In  addition  to 
enhancing  our  organic  growth,  we  will  also  consider  strategic  acquisitions  that  make  sense  in  terms  of 
complementary fit, cost and ease of integration.   

Grow the Agriculture Business  
We  will  continue  to  build-out  our  agriculture  business,  driving  awareness  and  exposure  for  our  advanced 
agriculture films, particularly Shine N’ Ripe XL and ADVASEAL®.  In conjunction with this, we will continue 
to work on the timely commercialization of ADVASEAL®.  Management believes the underlying technology 
platform behind both products brings substantial upside potential for the Company.   

Maintain focus on Research and Development  
We  will  maintain  our  focus  on  enhancing  the  customer  value  proposition,  developing  new  capabilities  and 
leading  edge  products  for  highly  profitable  niche  markets.    In  addition  to  building  out  our  core  flexible 
packaging product portfolio, we will also concentrate on introducing new proprietary technologies, in order to 
offer  solutions  that  are  more  cost  effective  and  environmentally-friendly  than  traditional  methods.    The 
Company’s research teams use the fields in which they have core-competencies in order to identify innovative 
improvements and solutions where chemicals and polymers can offer added-value. 

Fourth Quarter 2016 

4 

 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

GROWTH STRATEGY (continued) 

Maintain Efficiency of Equipment   
Finally, we will focus on the efficiency of our equipment, making the required capital investments to maintain, 
upgrade and expand into new areas.   Our commitment to make the required capital investments, and our ability 
to  deliver  customized  solutions,  on-time  and  at  competitive  prices  should  help  to  drive  revenue  and  margin 
expansion, while allowing us to remain competitive in the marketplace.  

EMPLOYEES AND CORPORATE OFFICE 

Imaflex currently employs 220 people worldwide and our corporate head office is located in Montreal, Canada.  
The Company currently has no unionized employees.   

OUTSOURCING 

Our industry is capital intensive.  Labour is only a minor component in the total cost of production. As a result, 
outsourcing  production  to  countries  with  lower  wages  would  not  have  a  material  impact  on  costs,  especially 
when factoring in expenses related to freight and duty.  

Furthermore, the risks associated with quality and on-time delivery would far outweigh any minimal benefit to 
our  customers  that  would  be  generated  by  lower  labour  costs.  Accordingly,  management  does  not  currently 
have an outsourcing strategy in place. 

NON-IFRS FINANCIAL MEASURES 

The Company’s management uses a non-IFRS financial measure in this MD&A, namely EBITDA, to assess its 
performance.  EBITDA is determined as “Earnings before interest, taxes, depreciation and amortization”. The 
reader may refer to the table below for the reconciliation of the EBITDA used by the Company to its reported 
net income. 

Reconciliation of EBITDA to net income: 
($ thousands, except per share data) 

Net income 
Plus: 
Income taxes 
Finance costs 
Depreciation and amortization 
EBITDA 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

 $ 161 

 $ 317 

 $ 408 

 $ 813 

213 
136 
561 
$ 1,071 

291 
147 
403 
$ 1,158 

589 
549 
2,001 
$ 3,547 

709 
601 
1,682 
$ 3,805 

Basic and diluted EBITDA per share * 

$ 0.022 

$ 0.023 

$ 0.071 

$ 0.077 

*Basic weighted average number of shares outstanding of 49,738,637 for the quarter ended December 31, 2016 
(49,638,637  in  2015)  and  49,697,653  for  the  year  ended  December  31,  2016  (49,517,502  in  2015).  Diluted 
weighted  average  number  of  shares  outstanding  of  49,784,681  for  the  quarter  ended  December 31,  2016 
(49,705,847 in 2015) and 49,724,435 for the year ended December 31, 2016 (49,593,417 in 2015). 

While  EBITDA  is  not  a  standard  IFRS  measure,  management,  analysts,  investors  and  others  use  it  as  an 
indicator  of  the  Company’s  financial  and  operating  management  and  performance.    EBITDA  should  not  be 
construed as an alternative to net income determined in accordance with IFRS as an indicator of the Company’s 
performance.  The  Company’s  method  of  calculating  EBITDA  may  be  different  from  those  used  by  other 
companies and accordingly it should not be considered in isolation. 

Fourth Quarter 2016 

5 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

RISK FACTORS 

The  Company  is  involved  in  a  competitive  industry  and  marketplace  in  which  there  are  a  number  of 
participants.    To  accommodate  and  effectively  manage  future  growth,  the  Company  continues  to  improve  its 
operational, financial and management information systems, as well as its production procedures and controls.  
The Company’s success is largely the result of the continued contributions of its employees and the Company’s 
ability to attract and retain qualified management, sales and operational personnel. 

The market the Company competes in has historically shown resiliency and growth even at the worst economic 
times. The Company’s customers operate predominantly in the food packaging and agriculture markets.  This 
fact,  coupled  with  the  expanding  product  lines  and  reliance  on  newer  and  faster  equipment,  should  help  it 
weather the potential volatility caused by uncertainty in the North American economic climate. 

Factors which can impact the Company include, but are not limited to: management of credit, market dynamics, 
liquidity, funding and operational risks; the strength of the Canadian and U.S. economies in which we conduct 
business; the impact of the movement of the Canadian dollar relative to other currencies, particularly the U.S. 
dollar; the effects of changes in interest rates; the effects of competition in the markets in which we operate; our 
ability  to  successfully  align  our  organization,  resources,  and  processes;  the  availability  and  price  of  raw 
materials; failure to achieve planned growth associated with the U.S. operations; changes in accounting policies 
and methods we use to report our financial condition, including uncertainties associated with critical accounting 
assumptions and estimates; operational and infrastructure risks; other factors may affect future results including, 
but  not  limited  to,  timely  development  and  introduction  of  new  products  and  services;  changes  in  tax  laws, 
technological  changes  and  new  regulations;  the  possible  impact  on  our  businesses  from  public-health 
emergencies, international conflicts and other developments; and our success in anticipating and managing the 
foregoing risks. 

GENERAL SITUATION OF THE POLYETHYLENE BLOWN FILM MARKET 

Although polyethylene prices experienced an increase in the fourth quarter of 2016, overall the market is still 
expecting supply to be greater than demand and therefore there is no upwards pressure expected on pricing in 
2017, much as was the case in 2016. Although resin suppliers will most definitely implement price adjustments 
in the year, the additional capacity that is expected to come on board should keep resin prices relatively flat in 
the long run. 

LOSS OF BUSINESS FROM A SIGNIFICANT CUSTOMER 

One of our business practices has been to limit the purchases by any particular customer to less than 15% of our 
revenues. This strategy ensures us that our profitability and financial well-being are not dependent on any one 
client.   

COMPETITION FROM OTHER COMPANIES 

Competition in our market is at the moment quite intense. Nevertheless, we are in a US$28 billion market and 
we  believe  we  have  a  competitive  edge  over  our  competition  because  we  have  highly  skilled  teams  that  are 
quick to respond to customer needs, we have a diversified  manufacturing base and the bulk of our customers 
deal in food related products. It may not always translate into a greater net profit, but should result in customer 
loyalty if we decide to match our competitors’ prices. 

SEASONALITY OF OPERATIONS 

Some products produced in our Victoriaville and Thomasville facilities are subject to seasonality as a result of 
their  partial  manufacturing  focus  in  the  production  of  agricultural  film  products  sold  to  fruit  and  vegetable 
growers. Customer demand in this end-market peaks twice yearly. Inventory is managed in a way to optimize 
cash flow while remaining able to react to any market opportunities that present themselves. However, because 
these locations also manufacture products that are destined for other markets which are not affected by seasonal 
downturns, these two plants are still able to operate all year, albeit at lower capacity levels.   

Fourth Quarter 2016 

6 

 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

EXPOSURE TO PRODUCT LIABILITY 

Due to the nature of our operations, which consist primarily of manufacturing polyethylene film for converters, 
who process the film into a finished product for their end-customers, Imaflex’s exposure to product liability is 
low.    Imaflex  is  not  exposed  to  liability  for  personal  injury  or  death  arising  from  negligence  in  the 
manufacturing of the films either. 

The  only  market  segment  that  exposes  the  Company  to  potential  product  liability  claims  is  the  agricultural 
market.  In  this  market,  proof  of  negligence  in  our  manufacturing  process  could  entail  some  form  of 
compensation in the event that the expected crop yields do not materialize. 

Although  the  likelihood  of  a  claim  in  this  market  is  low,  we  are  nonetheless  covered  by  a  product  liability 
insurance policy in the amount of $ 25,000,000. 

FLUCTUATIONS IN OPERATING RESULTS 

It is important to note that profitability may vary from quarter to quarter, irrespective of quarterly sales. This is 
due  to  many  factors,  including  and  not  limited  to:  competitive  conditions  in  the  businesses  in  which  the 
Company participates; general economic conditions and normal business uncertainty; product mix; fluctuations 
in  foreign  currency  exchange  rates;  the  availability  and  costs  of  raw  materials;  changes  in  the  Company’s 
relationship with its suppliers; and interest rate fluctuations and other changes in borrowing costs. 

EXPOSURE TO INTEREST RATE FLUCTUATIONS 

The  Company’s  borrowings  which  bear  interest  at  a  variable  rate  do  present  interest  rate  risk.  Management 
assesses  its  exposure  to  interest  rate  fluctuations  and  decides  whether  it  may  be  favourable  to  enter  into 
contracts to hedge this risk based on expectation of future movements and the available economic data. For the 
moment, management is not hedging any of its interest rate exposure and expects this exposure to decrease as 
the outstanding balance of its long term borrowings decreases. 

ABILITY TO ATTRACT AND RETAIN QUALIFIED PERSONNEL 

Imaflex’s  core  operational  management  team  has  been  stable  over  the  past  years  and  was  able  to  keep  key 
competencies  within  the  Company.  This  is  because  the  three  founders,  who  have  more  than  100  years  of 
combined  experience  in  management  and  research  and  development,  were  and  remain  at  the  core  of  its 
management  team.  As  the  Company  has  grown,  it  has  strengthened  its  team  with  the  addition  of  individuals 
having a variety of competencies, be it accounting, operations, or engineering.  

This has resulted in a work environment that allows for the free exchange of ideas in an effort to ensure that the 
Company remains at the forefront of our industry. We are confident that we can retain and, if need be, attract 
qualified individuals that will contribute to our quest of building shareholder value. 

MANAGEMENT OF GROWTH 

Imaflex’s history attests to its management’s ability to create and manage growth and to successfully adapt to 
prevailing and continuously changing market conditions. Management believes that future success will also lie 
in  the  ability  to  properly  manage  growth  whether  it  comes  from  new  markets  and  products,  acquisitions, 
mergers, or a combination of any or all three.  This success will depend on the Company’s ability to seek out 
new opportunities and to position itself such that it will be able to take advantage of them when they present 
themselves.  Past decisions have been made bearing this in mind and the Company is now in a better position to 
make this happen. 

Fourth Quarter 2016 

7 

 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

FOREIGN EXCHANGE FLUCTUATIONS 

A portion of the Company’s sales and expenses as well as accounts receivable and payable are denominated in 
USD. A portion of the revenue stream in USD acts as a natural hedge to cover expenses denominated in USD. 
The  Company  also  has  the  possibility  of  borrowing  amounts  on  its  line  of  credit  in  USD.  The  Company  has 
increased  its  debt  in  USD  to  obtain  additional  revenue  streams  in  USD.  When  this  additional  business  fully 
materializes,  the  Company’s  exposure  to  foreign  currency  should  be  managed  naturally.  Management 
continuously  assesses  its  exposure  to  such  risk  and  the  Company  does  not  currently  use  any  financial 
instruments to hedge its foreign currency position. 

ENVIRONMENTAL HAZARDS 

The Company’s raw materials, processes and finished goods do not have any hazardous implications. However 
we  do  buy  a  few  items  which  are  used  in  our  production  equipment  such  as  cooling  products  which  may  be 
hazardous, but their use and manipulation are controlled. Though these products actually pose little risk, they 
are handled in a manner that fully complies with existing safety regulations. 

RESULTS OF OPERATIONS 

Sales continued to grow in the fourth quarter of 2016 compared to the corresponding quarter of 2015, leading to 
higher sales and gross profits for the full year 2016. Going forward, as the Company continues to introduce new 
products to the market, it will build on its solid foundation to further improve sales volumes and profitability. 

($ thousands) 

Sales 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$18,943 

$17,084 

$73,513 

$69,151 

Sales increased by $1.9 million, or 10.9%, in the fourth quarter of 2016 compared to the same period in 2015, 
mainly due to higher sales prices following a favorable change in the product mix during the quarter. Sales in 
the  US  subsidiary  also  increased  due  to  management’s  efforts  to  stimulate  growth  in  our  operations  and  the 
fourth  quarter  demonstrated  positive  results  on  that  front.  To  a  lesser  extent,  foreign  exchange  also  had  a 
positive impact on sales in the fourth quarter of 2016 due to a stronger USD throughout the period, despite the 
fact that the USD closed stronger in 2015 than in 2016. 

For the year ended December 31, 2016, sales increased by $4.4 million, or 6.3%, compared to fiscal 2015. The 
increase in the sales price, which was also stimulated by a stronger USD throughout the year, was an important 
factor in the increase in sales. The Company’s sales volume also increased, most notably in the core packaging 
business, further contributing to the growth in sales. 

Fourth Quarter 2016 

8 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

RESULTS OF OPERATIONS (continued) 

($ thousands) 

Gross Profit ($) before 
amortization of production 
equipment 

Gross margin (%) 
Amortization of production 
equipment 
Gross profit ($) 
Gross margin (%) 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$2,538 

$2,704 

$10,186 

$8,520 

13.4% 
552 

$1,986 
10.5% 

15.8% 
332 

$2,372 
13.9% 

13.9% 
1,772 

$8,414 
11.4% 

12.3% 
1,412 

$7,108 
10.3% 

The Company’s gross profit before the amortization of production equipment decreased by $0.2 million or 6.1% 
during  the  quarter  ended  December  31,  2016  compared  to  the  same  period  in  2015  and  the  associated  gross 
margin decreased from 15.8% in 2015 to 13.4% in 2016. The amortization of production equipment increased 
in  the  fourth  quarter  of  2016  due  to  the  assets  purchased  throughout  the  year.  The  Canadian  operations 
maintained a strong gross profit in the fourth quarter of 2016 whereas the US experienced a decrease due to an 
unfavourable  change  in  product  mix.  Moreover,  higher  resin  prices  from  suppliers  negatively  impacted  the 
gross profit as the Company was only able to reflect the increase in its pricing after a month’s delay. 

For  the  year  ended  December  31,  2016,  the  gross  profit  before  the  amortization  of  production  equipment 
increased by $1.7 million compared to the year ended December 31, 2015 and the gross margin increased from 
12.3% in 2015 to 13.9% in 2016. Although the amortization of production equipment increased in fiscal 2016 
due  to  equipment  purchases,  the  gross  profit  increased  by  $1.3  million  in  fiscal  2016  over  fiscal  2015.  The 
Company  generated  more  operational  profitability  in  fiscal  2016  compared  to  2015  following  the  increase  in 
sales  and  improved  operational  efficiencies  achieved  during  the  year.  These  improvements  reflect 
management’s ongoing efforts to drive operational efficiencies throughout the business and support growth in 
an efficient manner. 

($ thousands) 

Selling and administrative 

As a % of sales 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$1,623 

8.6% 

$1,475 

8.6% 

$6,497 

8.8% 

$6,211 

9.0% 

Selling  and  administrative  expenses  increased  by  $0.1  million  in  the  fourth  quarter  of  2016  compared  to  the 
same period in 2015, mainly as a result of the increase in sales and administrative salaries. The stronger USD 
also  had  an  impact  on  selling  and  administrative  expenses.  As  a  percentage  of  sales  however,  selling  and 
administrative expenses remained constant at 8.6% in both fiscal 2015 and 2016 due to the higher revenue base. 

Despite the increase in sales and production volumes, growth in fiscal 2016 selling and administrative expenses 
was  limited  to  $0.3  million  due  to  controlled  spending  during  the  year.  As  a  percentage  of  sales,  selling  and 
administrative  expenses  decreased  from  9.0%  in  2015  to  8.8%  in  2016  due  to  the  higher  revenue  base  and 
ongoing cost control efforts. Management remains focused on managing selling and administrative expenses as 
the Company continues to grow. 

Fourth Quarter 2016 

9 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

RESULTS OF OPERATIONS (continued) 

($ thousands) 

Finance costs 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$136 

$147 

$549 

$601 

Due to the lower amount outstanding under the Company’s line of credit and USD loan in the fourth quarter of 
2016,  finance  expenses  decreased  slightly  compared  to  the  same  period  in  2015.  The  Company  refinanced  a 
loan during the fourth quarter of 2016, obtaining additional capital and increasing the balance outstanding on 
that loan, which partly offset the decrease in finance costs on the line of credit and the USD loan. 

Finance costs decreased during the year ended December 31, 2016 compared to the year ended December 31, 
2015 mainly due to the decreasing balances on long term loans, despite the additional capital that was obtained 
at the end of fiscal 2016 after a loan was refinanced. 

($ thousands) 

Three months ended 

Years ended 

Foreign exchange (gains)/losses 

December 31,
2016
$ (162) 

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$ 124 

$ 291 

$ (1,296) 

The depreciation of the CAD against the USD over the fourth quarter of 2016 led to a gain on foreign exchange 
of $0.2 million, whereas the depreciation of the CAD against the USD over the fourth quarter of 2015 led to a 
loss  of  $0.1  million.  Variations  in  the  Company’s  exposure  and  movements  of  accounts  in  foreign  currency, 
including  transactions  with  the  Company’s  US  subsidiary,  led  to  a  positive  swing  in  results  of  $0.3  million 
quarter over quarter. 

The slight appreciation of the CAD against the USD throughout fiscal 2016 led to a foreign exchange loss of 
$0.3 million, whereas the important depreciation of the CAD against the USD throughout fiscal 2015 led to an 
important  foreign  exchange  gain  of  $1.3  million.  Movements  in  foreign  exchange  therefore  had  a  negative 
impact of $1.6 million on year over year results, largely offsetting the improvements achieved in the Company’s 
operations. 

($ thousands) 

Income taxes 

As a % of profit before taxes 

Three months ended 

Years ended 

December 31,
2016

December 31, 
2015

December 31, 
2016 

December 31, 
2015

$ 213 

57.0% 

$ 291 

47.9% 

$ 589 

59.1% 

$ 709 

46.6% 

The  income  tax  expense  amounted  to  $0.2  million  in  the  fourth  quarter  of  2016  compared  to  an  expense  of 
$0.3 million for the same period in 2015. The income tax expense represented 57.0% of profit before tax, which 
is higher than the statutory income tax rate and the 47.9% in fiscal 2015. 

For  fiscal  2016,  the  income  tax  expense  amounted  to  $0.6  million  compared  to  $0.7  million  for  the 
corresponding period in 2015 and increased as a percentage of profit before tax, increasing from 46.6% in 2015 
to  59.1%  in  2016.  This  is  higher  than  the  statutory  income  tax  rate  because  for  both  years  no  benefit  was 
recorded for the losses of the US subsidiary. 

Fourth Quarter 2016 

10 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

RESULTS OF OPERATIONS (continued) 

($ thousands, except per share data) 

Three months ended 

Years ended 

Net income 

December 31,
2016

$ 161 

December 31, 
2015
$ 317 

Basic and diluted earnings per share 

$ 0.003 

$ 0.006 

December 31, 
2016 

December 31, 
2015

$ 408 

$ 0.008 

$ 813 

$ 0.016 

The  Company’s  net  income  decreased  slightly  in  the  fourth  quarter,  going  from  $0.3  million  in  2015  to 
$0.2 million  in  2016.  The  decrease  reflects  the  lower  gross  profit  and  the  higher  selling  and  administrative 
expenses, partially offset by favorable foreign exchange movements and a lower income tax expense. The basic 
and diluted EPS decreased, from $0.006 in 2015 to $0.003 in 2016. 

For  fiscal  2016,  net  income  was  $0.4  million,  decreasing  from  $0.8  million  in  fiscal  2015,  mainly  due  to  the 
large swing in foreign exchange. In 2015, the US dollar appreciated significantly from the beginning to the end 
of  the  year,  whereas  in  2016  the  Company  saw  more  stability  in  the  currencies  with  which  it  operates. 
Operationally, the Company’s profitability improved significantly and increases in other expenses were limited, 
which positions the Company for further improvements to net income if sales volumes continue to grow as seen 
in recent years. 

Financial Position 

December 31, 2016 vs. December 31, 2015 

The Company’s short term assets and liabilities decreased from December 31, 2015 to December 31, 2016. A 
greater  decrease  in  current  liabilities  improved  the  Company’s  financial  position  as  the  increase  in  long  term 
borrowings,  combined  with  the  increased  profitability  over  the  period,  provided  the  liquidities  needed  to 
decrease the short-term bank indebtedness. The Company’s working capital increased from $4.9 million in 2015 
to  $6.0 million  in  2016.  Trade  and  other  receivables  and  prepaid  expenses  also  decreased,  each  by 
approximately  $0.1 million,  and  trade  payables  and  the  current  tax  liabilities  decreased,  by  $0.1  million  and 
$0.2 million  respectively.  Overall,  the  Company  maintains  a  solid  financial  position  placing  it  in  a  good 
position to support future growth. 

SUMMARY OF QUARTERLY RESULTS 

Summary financial data derived from the Company’s unaudited quarterly financial statements for each of the 
eight most recently completed quarters are as follows: 

For the quarters ending March, June, September and December ($ thousands, except per share data): 

Q4/16  Q3/16  Q2/16  Q1/16  Q4/15  Q3/15  Q2/15  Q1/15 
15,910
18,943 
(293)
161 

16,997  18,195
523

18,716 
345 

17,441
444

17,084
317

19,378
(172)

(104) 

Revenues 
Net income 
(loss) 

Earnings (loss) per share: 
  Basic and  
diluted 

0.003 

(0.002) 

0.010

(0.003)

0.006

0.009

0.007 

(0.006)

It is important to note that profitability may vary from quarter to quarter, irrespective of quarterly sales due to 
many factors.  These factors include and are not limited to: competitive conditions in the businesses in which 
the  Company  participates;  general  economic  conditions  and  normal  business  uncertainty;  product  mix; 
fluctuations  in  foreign  currency  rates;  the  availability  and  costs  of  raw  materials;  changes  in  the  Company’s 
relationship with its suppliers; and interest rate fluctuations and other changes in borrowing costs. 

Fourth Quarter 2016 

11 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

LIQUIDITY 

The  Company’s  working  capital  increased  from  $ 4.9  million  as  at  December  31,  2015  to  $ 6.0  million  as  at 
December  31,  2016.  Short  term  assets  decreased  by  $ 1.1  million,  mainly  due  to  the $0.7 million  decrease  in 
inventories. Accounts receivable and prepaid expenses also decreased, each by approximately $0.1 million, and 
over the period the Company’s cash position also decreased by $0.1 million. Current liabilities decreased more 
significantly than current assets, driven by the $1.9 million decrease in bank indebtedness. The Company repaid 
an important amount on its short term bank debt following increased profitability and the inflow obtained after a 
loan  was  refinanced  late  in  the  year.  Trade  payables  decreased  by  $0.1  million  and  current  tax  payable  also 
decreased, by $0.2 million. The current portion of long term debt remained fairly stable and the current portion 
of finance leases increased by $17 thousand over the period.  

Cash Flows from Operating Activities 

The  strong  profitability  over  the  quarter  fueled  improvements  in  the  Company’s  operating  cash  flow,  with 
operating cash flow before movements in working capital totaling $0.9 million for the fourth quarter of 2016. 
These inflows were only partially offset by a $0.2 million outflow due to movements in working capital and a 
$0.2 million outflow for payments of income taxes. Total operating cash flow amounted to $0.5 million. During 
the  fourth  quarter  of  2015,  before  movements  in  working  capital,  operating  activities  generated  inflows  of 
$ 0.7 million,  coming  in  lower  than  in  2016,  which  were  entirely  offset  by  important  outflows  due  to 
movements  in  working  capital  and  the  payment  of  income  taxes,  for  a  net  operational  cash  outflow  of 
$1.6 million. 

The  operating  cash  flow  for  fiscal  2016  improved  significantly,  generating  an  inflow  of  $4.2 million  before 
movements  in  working  capital  due  to  the  increased  profitability  for  the  year.  Movements  in  working  capital 
generated  inflows  of  $0.7 million,  mainly  due  to  the  $0.6  million  decrease  in  inventories  and,  net  of  the 
$0.8 million  payment  of  income  taxes,  operating  activities  generated  inflows  of  $4.1 million.  During  fiscal 
2015, operating cash flow before movements in working capital generated inflows of $2.1 million, as the large 
unrealized  foreign  exchange  gain  offset  a  portion  of the  cash  inflows  generated  by  operations.  These  inflows 
were also offset by the $1.5 million outflow due to movements in working capital and the $0.5 million payment 
of income taxes, generating net cash inflows of only $0.1 million. 

Cash Flows from Investing Activities 

During the fourth quarter of 2016, the Company invested an additional $ 0.3 million in capital assets and non-
current assets, mainly for small pieces of auxiliary equipment and to improve existing equipment. During the 
same quarter in 2015, the Company invested $ 0.3 million for small equipment and leasehold improvements. 

During  fiscal  2016,  the  Company  invested  $1.5 million  in  long  term  assets,  mainly  for  the  improvement  to 
existing  equipment  in  order  to  operate  more  efficiently.  This  amount  is  slightly  lower  than  the  $1.6 million 
invested  in  fiscal  2015  for  the  refurbishing  of  its  machinery,  for  analytical  equipment  and  for  leasehold 
improvements. 

Cash Flows from Financing Activities 

During  the  fourth  quarter  of  2016,  the  Company  reimbursed  $1.0 million  on  its  short  term  bank  debt, 
$0.2 million  on  long  term  debt,  $42 thousand  on  finance  leases  and  made  interest  payments  amounting  to 
$0.1 million.  During  the  quarter,  the  Company  received  an  additional  $1.0 million  by  refinancing  an  existing 
long  term  loan  following  the  purchase  of  long  term  assets.  In  the  fourth  quarter  of  2015,  the  Company  used 
$2.3 million of its line of credit for operations, reimbursed $0.3 million on long term debt and $37 thousand on 
obligations under finance leases. The Company also paid $0.1 million in interest. 

Fourth Quarter 2016 

12 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

LIQUIDITY (continued) 

Cash Flows from Financing Activities (continued) 

During fiscal 2016, the Company reimbursed $ 1.9 million on its short term bank indebtedness, $ 1.0 million on 
its  long  term  debt,  $0.2  million  on  finance  leases  and  paid  $0.5 million  in  interest.  The  Company  obtained 
$1.0 million by refinancing a long term loan and issued shares for proceeds of $12 thousand. In fiscal 2015, the 
Company borrowed $1.8 million on its line of credit and $0.6 million in term debt. A share issuance generated 
proceeds  of  $0.3 million  during  the  year.  Moreover,  the  Company  reimbursed  $1.1 million  on  long  term 
borrowings,  $0.2  million  to  a  shareholder,  $0.1  million  under  its  obligations  under  finance  leases  and  paid 
$0.6 million in interest. 

CONTRACTUAL OBLIGATIONS 

The contractual obligations as at December 31, 2016 were as follows: 

 ($ thousands) 

Long-term debt 
Finance leases 
Operating leases 
Bank Indebtedness 
Total contractual obligations 

Total 

$  6,100
415
6,011
5,052
$ 17,578

Payments due by period 
1 – 5 years 
Less than 1 
year 

After 5 years 

$ 1,566
185
931
5,052
$ 7,734

$ 4,079 
230 
3,206 
- 
$ 7,515 

$  455
-
1,874
-
$ 2,329

These  contractual  obligations  are  sensitive  to  the  fluctuation  of  interest  rates.  These  obligations  are  based  on 
interest rates and foreign exchange rates effective as at December 31, 2016. 

CAPITAL RESOURCES 

The Company has an operating line of credit with its bankers to a maximum of $ 10 million bearing interest at a 
rate of prime plus 0.90%. The line of credit is secured by trade receivables and inventories. As at December 31, 
2016, the Company was using $ 5.1 million on its line of credit ($ 6.9 million as at December 31, 2015). The 
Company’s working capital improved, reaching $6.0 million as at December 31, 2016 compared to $4.9 million 
as at December 31, 2015. The Company has a solid financial position and its profitability and the refinancing of 
a long term loan provided additional capital, permitting the Company to decrease short term borrowings. The 
Company  currently  has  sufficient  liquidity  to  finance  its  current  operations  and  the  short  term  growth  that  is 
expected in the year to come. 

PROPOSED TRANSACTION 

The Company is not currently contemplating any business acquisition or merger. 

RELATED PARTY TRANSACTIONS 

In  the  normal  course  of  operations,  the  Company  had  routine  transactions  with  related  parties.    These 
transactions are measured at fair value, which is the amount of consideration established and agreed to by the 
related parties. 

The  following  table  reflects  the  related  party  transactions  recorded  for  the  periods  ended  December  31,  2016 
and 2015. For additional information, please refer to note 24, Related party transactions of the “Notes to the 
consolidated financial statements” for the years ended December 31, 2016 and 2015. 

Fourth Quarter 2016 

13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

RELATED PARTY TRANSACTIONS (continued) 

($ thousands) 
(unaudited) 

Professional fees and key 
management personnel services 
Rent 
Remuneration 

(a) 

(b) 
(c) 

Three months ended 

December 31,
2016

$   108 

December 31, 
2015
$ (4) 

$ 233 
$ 398 

$ 234 
$ 182 

Years ended 

December 31, 
2016 

$ 284 

$ 878 
$ 975 

December 31, 
2015
$  221 

$ 825 
$ 744 

 (a) Professional fees include transactions with Polytechnomics Inc., of which Gerald R. Phelps, Imaflex’s Vice-
President – Operations, is the controlling shareholder and with Philip Nolan, a director of Imaflex, who is also a 
partner at Lavery de Billy L.L.P. 

 (b)  Joseph  Abbandonato,  Imaflex’s  President,  Chief  Executive  Officer  and  Chairman  of  the  Board,  is  the 
controlling  shareholder  of  Roncon  Consultants  Inc.  (“Roncon”).    The  Company’s  production  facilities  at 
Imaflex,  Canslit,  and  Imaflex  USA  are  leased  from  Roncon  and  parties  related  to  Roncon  under  long-term 
operating lease agreements (see “Contractual Obligations”). 

(c) Includes salaries, benefits and fees paid to key management personnel and directors. 

CRITICAL ACCOUNTING POLICIES 

The  Company’s  significant  accounting  policies  are  disclosed  in  note  2,  Significant  accounting  policies  of  the 
consolidated  financial  statements  for  the  years  ended  December  31,  2016  and  2015.  This  note  explains  the 
Company’s accounting policies under IFRS which have not changed since the Company’s last annual financial 
statements. 

FINANCIAL INSTRUMENTS 

Please  refer  to  note  21,  Financial  instruments  of  the  consolidated  financial  statements  for  the  years  ended 
December  31,  2016  and  2015  for  disclosure  on  the Company’s  financial  instruments  as  well  as  note  23,  Risk 
management for a discussion on the risks the Company is exposed to and how they are managed. 

As at December 31, 2016, the Company is not using any swap, forward or hedge accounting and there were no 
warrants outstanding. 

As at December 31, 2016, 2,450,000 options to purchase shares of the Company were outstanding at a weighted 
average strike price of $0.436 of which 937,500 were exercisable. During the year ended December 31, 2016, 
the  Company  issued  500,000  options  to  purchase  shares  of  the  Company  at  an  exercise  price  of  $ 0.42  and 
1,300,000 options to purchase shares of the Company at $0.40 for a period of five years. During the year ended  
December  31,  2016,  the  Company  issued  100,000  shares  following  the  exercise  of  options  for  a  cash 
consideration of $ 12,500. 

As at December 31, 2015, 750,000 options to purchase shares of the Company were outstanding at a weighted 
average strike price of $ 0.467 and 262,500 were exercisable. As at December 31, 2015, there were no warrants 
outstanding,  but  during  the  year  2,824,363  warrants  entitling  the  holder  to  purchase  shares  of  the  Company 
expired  and  1,381,695  warrants  to  purchase  a  common  share  for  $ 0.45  were  exercised  for  total  proceeds  of 
$ 621,762, a portion of which was received during fiscal 2014. 

Fourth Quarter 2016 

14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT DISCUSSION AND ANALYSIS  

MANAGEMENT OUTLOOK 

All indications are that citrus film sales have now taken root.  This new revenue stream should bolster sales and 
profitability as market adoption increases.  Furthermore, our ability to offer unique products, combined with our 
commitment  to  make  the  required  investments  in  order  to  monetize  them,  should  allow  us  to  drive  further 
revenue and margin expansion.  With a much improved balance sheet, an unwavering focus on operational and 
financial excellence and an innovative team, we believe we are well placed to capitalize on market opportunities 
and drive sustained profitable growth.     

Imaflex expects 2017 revenues to grow by approximately 10% over 2016.       

OUTSTANDING SHARE DATA 

As  at  December  31,  2016,  the  Company  had  49,738,637  common  shares  outstanding  (49,638,637  as  at 
December 31, 2015). 

RISK FACTORS 

The  Company  is  involved  in  a  competitive  industry  and  marketplace  in  which  there  are  a  number  of 
participants.  To effectively manage future growth, the Company continues to improve its operational, financial 
and management information systems, procedures and controls.  The Company’s success is largely the result of 
the  continued  contributions  of  its  employees  and  the  Company’s  ability  to  attract  and  retain  qualified 
management, sales and operational personnel. 

The US$28 billion market the Company competes in has historically shown resiliency and growth even at the 
worst economic times. The Company’s customers operate predominantly in the food packaging and agricultural 
markets. This fact, coupled with the expanding product lines and reliance on newer and faster equipment should 
help it weather the potential volatility caused by uncertainty in the North American economic climate. 

Factors which can impact the Company include, but are not limited to: management of credit, market dynamics, 
liquidity, funding and operational risks; the strength of the Canadian and U.S. economies in which we conduct 
business; the impact of the movement of the Canadian dollar relative to other currencies, particularly the U.S. 
dollar; the effects of changes in interest rates; the effects of competition in the markets in which we operate; our 
ability  to  successfully  align  our  organization,  resources,  and  processes;  the  availability  and  price  of  raw 
materials; failure to achieve planned growth associated with the U.S. operations; changes in accounting policies 
and methods we use to report our financial condition, including uncertainties associated with critical accounting 
assumptions and estimates; operational and infrastructure risks; other factors may affect future results including, 
but  not  limited  to,  timely  development  and  introduction  of  new  products  and  services,  changes  in  tax  laws, 
technological changes, new regulations; the possible impact on our businesses from public-health emergencies, 
international  conflicts  and  other  developments;  and  our  success  in  anticipating  and  managing  the  foregoing 
risks. 

Additional  information  relating  to  our  Company,  including  our  Annual  Report,  can  be  found  on  SEDAR  at 
www.sedar.com. 

(s) Joe Abbandonato 
Joe Abbandonato 
President and Chief Executive Officer 

(s) Giancarlo Santella   
Giancarlo Santella, CPA, CA 
Corporate Controller 

April 18, 2016 

Fourth Quarter 2016 

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Financial Statements of  
IMAFLEX INC. 

Years ended December 31, 2016 and 2015 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditor’s Report

To the Shareholders of
Imaflex Inc.

We have audited the accompanying consolidated financial statements of Imaflex 
Inc., which comprise the consolidated statements of financial position as at 
December 31, 2016 and 2015 and the consolidated statements of comprehensive 
income, changes in equity and cash flows for the years then ended, and a 
summary of significant accounting policies and other explanatory information.

Management’s responsibility for the consolidated financial statements 

Management is responsible for the preparation and fair presentation of these
consolidated financial statements in accordance with International Financial 
Reporting Standards (IFRS) and for such internal control as management 
determines is necessary to enable the preparation of consolidated financial 
statements that are free from material misstatement, whether due to fraud or error.

Auditor’s responsibility

Our responsibility is to express an opinion on these consolidated financial 
statements based on our audits. We conducted our audits in accordance with 
Canadian generally accepted auditing standards. Those standards require that we 
comply with ethical requirements and plan and perform the audit to obtain 
reasonable assurance about whether the consolidated financial statements are free 
from material misstatement.

An audit involves performing procedures to obtain audit evidence about the 
amounts and disclosures in the consolidated financial statements. The procedures 
selected depend on the auditor’s judgment, including the assessment of the risks of 
material misstatement of the consolidated financial statements, whether due to 
fraud or error. In making those risk assessments, the auditor considers internal 
control relevant to the entity’s preparation and fair presentation of the consolidated
financial statements in order to design audit procedures that are appropriate in the 
circumstances, but not for the purpose of expressing an opinion on the 
effectiveness of the entity’s internal control. An audit also includes evaluating the 
appropriateness of accounting policies used and the reasonableness of accounting 
estimates made by management, as well as evaluating the overall presentation of 
the consolidated financial statements.

 Raymond Chabot Grant Thornton LLP Suite 2000 National Bank Tower 600 De La Gauchetière Street West Montréal, Quebec  H3B 4L8  Telephone: 514-878-2691 Fax: 514-878-2127 www.rcgt.com  Member of Grant Thornton International Ltd 2

We believe that the audit evidence we have obtained in our audits is sufficient and 
appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the consolidated financial statements present fairly, in all material 
respects, the financial position of Imaflex Inc. as at December 31, 2016 and 2015
and its financial performance and its cash flows for the years then ended in 
accordance with International Financial Reporting Standards (IFRS).

Montréal
April 18, 2017

1 CPA auditor, CA public accountancy permit no. A119564

 
 
Consolidated statements of comprehensive income 
for the years ended 
(in Canadian dollars) 

December 31, 

          2016 

          2015 

Revenues 
Cost of sales 
Gross profit 

Expenses: 
Selling  
Administrative 
Finance costs 
Foreign exchange losses (gains) 
Other 

Income before income taxes 

Income taxes 

NET INCOME 

(Note 5.1)

$   73,513,424 
65,099,412 
8,414,012 

  $  69,150,630 
62,042,460 
7,108,170 

(Note 8)

1,541,833 
4,955,639 
548,940 
290,977 
79,549 
7,416,938 

1,735,052 
4,475,482 
601,298 
(1,296,335)
71,000 
5,586,497 

997,074 

1,521,673 

(Note 9)

589,007 

708,455 

408,067 

813,218 

Other comprehensive (loss)/income 
Item that will be reclassified subsequently to net income 
Exchange differences on translating foreign operations 

(136,297) 

801,108 

COMPREHENSIVE INCOME 

  $ 

271,770 

  $   1,614,326 

Earnings per share 
Basic and diluted  

(Note 10)

  $      

0.008 

  $  

0.016 

The accompanying notes are an integral part of these consolidated financial statements and note 6 presents 
additional information on consolidated comprehensive income. 

4 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated statements of financial position 
As at 

(in Canadian dollars) 
Assets 

Current assets 

Cash 
Trade and other receivables 
Inventories 
Prepaid expenses 
Total current assets 

Non-current assets 

Property, plant and equipment 
Intangible assets 
Total non-current assets 

Total assets 

Liabilities and equity  

Current liabilities 

December 31, 
2016 

  December 31,
2015

(Note 11)  
(Note 12)  

$  

68,100 
11,358,652 
10,074,571 
145,011 
21,646,334 

$ 

160,975
11,501,462
10,822,438
265,002
22,749,877

(Note 13)  
(Note 14)  

18,785,708 
1,485,177 
20,270,885  

19,601,217
1,484,370
21,085,587

$  41,917,219 

$  43,835,464

Bank indebtedness 
Trade and other payables 
Current tax liabilities 
Long-term debt, current portion 
Finance lease obligations, current portion 
Total current liabilities 

Non-current liabilities 

Long-term debt 
Deferred tax liabilities 
Finance lease obligations 
Total non-current liabilities 

Total liabilities 

Equity 

Share capital 
Reserves 
Retained earnings 
Total equity 

(Note 16)  
(Note 15)  

(Note 16)  
(Notes 16, 17)  

(Note 16)  
(Note 9)  
(Notes 16, 17)  

5,052,270 
8,749,001 
311,211 
1,355,760 
170,740 
15,638,982 

4,128,041 
1,291,493 
221,974 
5,641,508 

6,925,713
8,865,082
541,399
1,358,488
153,959
17,844,641

4,300,420
1,285,593
333,647
5,919,660

21,280,490 

23,764,301

(Note 18)  
(Note 19)  

11,765,023 
1,903,823 
6,967,883 
20,636,729 

11,752,523
1,758,824
6,559,816
20,071,163

Total liabilities and equity 

$  41,917,219 

$  43,835,464

Non-cancellable operating lease commitments (Note 22.3) 

The accompanying notes are an integral part of these consolidated financial statements. 

(s) Joseph Abbandonato 
Joseph Abbandonato 
Director 

(s) Gilles Émond 
Gilles Émond 
Director 

5 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated statements of changes in equity 
For the years ended December 31, 2016 and 2015 
(in Canadian dollars) 

Share 
capital (a) 
$ 10,945,614
-

Share-based 
compensation
$ 371,892
-

 Reserves 

Accumulated 
foreign 
currency 
translation  Warrants 

Other 

Total 
reserves 

$  18,009 
- 

$ 650,321    $  296,053   $  1,336,275
- 

- 

-

Retained 
earnings 
$ 5,746,598  $ 18,028,487 
813,218 

813,218 

Total 

-
-

-
-

801,108 
801,108 

- 
- 

-
-

801,108
801,108

- 
813,218 

801,108 
1,614,326 

806,909
-

-
102,641

- 
- 

(185,147)
- 

(296,053)
-

(481,200)
102,641

- 
- 

325,709 
102,641 

$11,752,523

$ 474,533

$  819,117 

$ 465,174    $ 

-   $ 1,758,824 

$ 6,559,816  $ 20,071,163 

-

-
-

-

-
-

- 

(136,297)
(136,297)

12,500
-
$11,765,023

-
281,296
$ 755,829

- 
- 
$  682,820 

- 

- 
- 

- 
- 

$ 465,174    $ 

-

-
-

- 

408,067 

408,067 

(136,297)
(136,297)

- 
408,067 

(136,297) 
271,770 

- 
-
-
281,296 
-   $ 1,903,823 

12,500 
281,296 
$ 6,967,883  $ 20,636,729 

- 
- 

Balance at January 1, 2015 
Net income for the year 
Exchange differences on translating 

foreign operations 

Comprehensive income for the year 

Transactions with owners: 
Issuance of share capital (Note 18) 
Share-based compensation (Note 19) 
Balance at December 31, 2015 and 
January 1, 2016 

Net income for the year 
Exchange differences on translating 

foreign operations 

Comprehensive income for the year 

Transactions with owners: 
Issuance of share capital (Note 18) 
Share-based compensation (Note 19) 
Balance at December 31, 2016 

(a) Additional detail of share capital is provided in Note 18 
The accompanying notes are an integral part of these consolidated financial statements.

6 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
Consolidated statements of cash flows 
for the years ended 
(in Canadian dollars) 

Operating activities: 
Net income for the year  
Income tax expense 
Depreciation and amortisation of non-current assets 
Finance costs 
Share-based compensation 
Unrealized foreign exchange loss (gain) 

Net changes in working capital 
  Decrease (increase) in trade and other receivables 
  Decrease (increase) in inventories 
  Decrease (increase) in prepaid expenses 

(Decrease) increase in trade and other payables 

Cash generated by operations 
Net income taxes paid 
Net cash generated by operating activities 

Investing activities: 
Payments for property, plant and equipment 
Payments for intangible assets 
Net cash used in investing activities 

Financing activities: 
Net change in bank indebtedness 
Interest paid 
Increase in long term debt 
Repayment of long-term debt 
Net proceeds from issuance of share capital and warrants 
Due to a shareholder and director  
Repayment of finance leases 
Net cash (used in) generated by financing activities 

Net decrease in cash 

Cash, beginning of the year 
Effects of foreign exchange differences on cash 

Cash, end of the year 

Non-cash transactions (Note 20) 

December 31, 

2016

2015

 $ 408,067 
589,007 
2,000,905 
548,940 
281,296 
343,279 
4,171,494 

75,411 
618,492 
115,013 
(81,931) 
726,985 

4,898,479 
(813,295) 
4,085,184 

$     813,218 
708,455 
1,681,891 
601,298 
102,641 
(1,759,890)
2,147,613 

(1,358,589)
(243,767)
(33,433)
161,057 
(1,474,732)

672,881 
(543,213)
129,668 

(1,447,246) 
(93,345) 
(1,540,591) 

(1,598,779)
(29,767)
(1,628,546)  

(1,873,443) 
(548,445) 
961,510 
(1,029,168) 
12,500 
- 
(158,395) 
(2,635,441) 

1,770,843 
(586,716)
587,023 
(1,059,012)
325,709 
(203,947)
(138,672)
695,228 

(90,848) 

(803,650)

160,975 
(2,027) 

945,744 
18,881 

$  68,100 

$      160,975 

The accompanying notes are an integral part of these consolidated financial statements. 

7 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

1. General information 

Imaflex Inc. (“the Parent Company”) is incorporated under the Canada Business Corporations Act.  Its 
registered office and headquarters are located at 5710 Notre-Dame Street West, Montreal, Quebec, Canada. 
The principal activities of the Parent Company and its subsidiary (together referred to as the “Company”) 
consist in the manufacture and sale of products for the flexible packaging industry, including polyethylene 
film and bags, as well as the metallization of plastic film for the agriculture and packaging industries.  The 
common shares of the Parent Company are listed for trading on the TSX Venture Exchange under the 
symbol “IFX”. 

2. Significant accounting policies 

The accounting policies set out below have been applied consistently to all periods presented in these 
consolidated financial statements. 

2.1 Basis of presentation and statement of compliance 

The consolidated financial statements have been prepared in accordance with International Financial 
Reporting Standards (“IFRS”) in effect on December 31, 2016. The consolidated financial statements were 
approved by the board of directors and authorized for issue on April 18, 2017. 

2.2 Basis of measurement 

The consolidated financial statements have been prepared using the historical cost basis. 

2.3 Basis of consolidation 

The consolidated financial statements include the accounts of the Parent Company and its subsidiary, 
Imaflex USA Inc. (“Imaflex USA”), a wholly owned entity, which both have a reporting period of December 
31. Imaflex Inc. is the Company’s ultimate parent. The Parent Company controls a subsidiary if it is 
exposed, or has rights, to variable returns from its involvement with the subsidiary and has the ability to 
affect those returns through its power over the subsidiary.  All intercompany transactions and balances are 
eliminated on consolidation. 

As at December 31, 2016 and 2015, Imaflex USA, the Company’s wholly owned subsidiary, manufactured 
flexible packaging and plastic film out of its two North Carolina, USA, plants. 

2.4 Foreign currencies 

The functional currency is the currency of the primary economic environment in which an entity operates. 
The financial statements of the Parent Company and its subsidiary that are consolidated into the Company’s 
financial statements are prepared in their respective functional currencies. The consolidated financial 
statements are expressed in Canadian dollars (“CAD”), which is also the functional currency of the Parent 
Company as well as the Company’s presentation currency. 

The assets and liabilities of the Company’s foreign subsidiary, Imaflex USA, whose functional currency is 
the US dollar (“USD”), are translated at the exchange rate in effect at the date of the consolidated statement 
of financial position. Revenues and expenses are translated at monthly average exchange rates over the 
reporting period. Exchange gains or losses arising from the translation of Imaflex USA’s financial 
statements are recognised as Accumulated foreign currency translation within Reserves. 

8 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.4 Foreign currencies (continued) 

In preparing the financial statements of the individual entities, transactions in currencies other than the 
entity’s functional currency are recorded at the exchange rates in effect on the date of the transactions. 
Monetary items denominated in foreign currencies are translated at the exchange rate prevailing at the end of 
the reporting period. Resulting gains and losses on foreign exchange are recorded in the consolidated 
statement of comprehensive income. 

Effective January 1, 2015, in light of a change in circumstances, the Company re-assessed its designation of 
US$4,000,000 of inter-company monetary non-trade advances for foreign currency accounting. As such, 
since that date, this portion of monetary non-trade advances from the Parent Company to its foreign 
operation for which settlement is determined to be neither planned nor likely in the foreseeable future is 
accounted for as forming part of the Company’s net investment in its foreign subsidiary. The foreign 
exchange gains and losses arising on these advances are therefore recognized as Accumulated foreign 
currency translation within reserves. This change in estimate was treated prospectively from that date and 
resulted in an amount of approximately $ 895,000 being recorded in shareholder’s equity instead of foreign 
exchange gains in the consolidated statement of comprehensive income for the year ended December 31, 
2015. The foreign exchange gains or losses on trade receivables and other monetary advances continue to be 
included in Foreign exchange gains in the consolidated statement of comprehensive income. 

2.5 Revenue recognition 

Revenues are generated almost exclusively from the sale of goods. Revenue is measured at the fair value of 
the consideration received or receivable, net of estimated returns, rebates and discounts, and is recognised 
when all the following conditions are satisfied: 

  The Company has transferred to the buyer the significant risks and rewards of ownership of the goods; 
  The Company retains neither continuing managerial involvement to the degree usually associated with 

ownership nor effective control over the goods sold; 
the amount of revenue can be measured reliably; 
it is probable that the economic benefits associated with the transaction will flow to the Company; and 
the costs incurred or to be incurred in respect of the transaction can be measured reliably. 

 
 
 

Revenue is recognised in accordance with the terms of sale, generally when goods are received by external 
customers. 

2.6 Income Tax 

Income tax expense comprises both current and deferred tax. Current tax is based on taxable income for the 
year. Taxable income differs from net income as reported in the consolidated statement of comprehensive 
income because of items of revenue or expense that are taxable or deductible in other years and items that 
are never taxable or deductible. The Company’s liability for current tax is calculated using tax rates that 
have been enacted or substantively enacted at the reporting period. 

Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in 
the consolidated statements of financial position and the corresponding tax basis used in the computation of 
taxable income. Deferred tax liabilities are generally recognised for all taxable temporary differences. 
Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is 
probable that future taxable income will be available against which the underlying tax loss or deductible 
temporary difference can be utilized.   

9 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.6 Income Tax (continued) 

Deferred tax assets and liabilities are calculated using the tax rates and laws enacted or substantively enacted 
at the reporting date and which are expected to apply in the period in which the liability is settled or the asset 
realized. 

Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax 
assets against current tax liabilities, when they relate to income taxes levied by the same taxation authority 
and when the Company intends to settle its current tax assets and liabilities on a net basis. 

Current and deferred taxes are recognised as an expense or income in net income, except when they relate to 
items that are recognised outside net income (whether in other comprehensive income or directly in equity), 
in which case the tax is also recognised outside net income. 

2.7 Earnings per share 

Earnings per share are calculated by dividing net income available for common shareholders by the weighted 
average number of common shares outstanding during the period. Diluted earnings per share is calculated by 
taking into consideration potentially issuable shares that would have a dilutive effect on earnings per share. 

2.8 Financial assets and financial liabilities 

Financial assets and financial liabilities are recognised when the Company becomes a party to the 
contractual provisions of the instrument. On initial recognition, financial instruments are measured at fair 
value adjusted for transaction costs except if directly attributable to the acquisition of financial assets. 

Financial assets 

For the purposes of subsequent measurement, financial assets are classified, upon initial recognition, in the 
different categories depending on their nature and purpose. 

The Company’s cash as well as trade and other receivables (excluding sales taxes) are classified as loans and 
receivables. Loans and receivables are non-derivative financial assets with fixed or determinable payments 
that are not quoted in an active market. After initial recognition, these are measured at amortised cost using 
the effective interest method, less any impairment. Discounting is omitted where the effect of discounting is 
immaterial. 

Impairment of financial assets 

Financial assets are assessed for indications of impairment at least at each reporting period. Financial assets 
are considered to be impaired when there is objective evidence that, as a result of one or more events that 
occurred after the initial recognition of the financial asset, the estimated future cash flows of the asset have 
been affected.  

Trade and other receivables that are assessed not to be impaired individually are, in addition, assessed for 
impairment on a collective basis. Objective evidence of impairment for a portfolio of receivables could 
include past experience of collecting payments, an increase in the number of delayed payments in the 
portfolio past the average credit period, as well as observable changes in economic conditions that correlate 
with default on receivables. 

10 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.8 Financial assets and financial liabilities (continued) 

The carrying amount for most financial assets is reduced by the impairment loss directly. For trade 
receivables, the carrying amount is reduced through the use of an allowance account. When a trade 
receivable is considered uncollectible, it is written off against the allowance account. Subsequent recoveries 
of amounts previously written off are credited against the allowance account. Changes in the carrying 
amount of the allowance account are recognised in net income. The expense relating to the allowance for 
doubtful accounts is recognised in Administrative expenses in the statement of comprehensive income. 

Financial liabilities 

Financial liabilities are measured subsequently at amortised cost using the effective interest rate method. 
Discounting is omitted where the effect of discounting is immaterial. 

The Company’s bank indebtedness, trade and other payables (excluding employee benefits) and long-term 
debt are classified as financial liabilities measured at amortised cost. All interest-related charges are 
recognised in the consolidated statement of comprehensive income under Finance costs. 

The Company derecognises financial liabilities when, and only when, the Company’s obligations are 
extinguished, discharged, cancelled or expired. 

2.9 Inventories 

Inventories are stated at the lower of cost and net realizable value. Costs, including raw materials and an 
appropriate portion of fixed and variable overhead expenses, are assigned to inventories by the method most 
appropriate to the particular class of inventory, being valued on a first-in, first-out basis. Net realizable value 
represents the estimated selling price for inventories less all estimated costs of completion necessary to make 
the sale and estimated selling expenses. 

2.10 Property, plant and equipment 

The Company’s building, land, production equipment, office equipment and computer equipment are stated 
at cost, including any costs directly attributable to bringing the assets to the location and condition necessary 
for it to be capable of operating in the manner intended by the Company’s management, less accumulated 
depreciation and accumulated impairment losses.  

Depreciation is recognised so as to write-down the cost of assets less their residual values over their useful 
lives, as outlined below, using the straight-line method. The estimated useful lives, residual values and 
depreciation method are reviewed and adjusted, if necessary, at each reporting date, with the effect of any 
changes in estimate accounted for on a prospective basis. 

Asset 

Land 
Building 
Production equipment 
Office equipment 
Computer equipment 

Period 

Indefinite 
20 years 
20 years 
5 years 
3 years 

11 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.10 Property, plant and equipment (continued) 

Leasehold improvements are amortised on a straight-line basis over the lesser of the terms of the leases or 
their useful lives (5 years). 

An item of property, plant and equipment is derecognised upon disposal or when no future economic 
benefits are expected to arise from the continued use of the asset. The gain or loss arising from the disposal 
or retirement of an item of property, plant and equipment is determined as the difference between the sales 
proceeds and the carrying amount of the asset and is recognised in net income, in Other in the consolidated 
statement of comprehensive income. 

2.11 Leased assets 

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and 
rewards of ownership to the lessee. All other leases are classified as operating leases. 

Assets held under finance leases are initially recognised as assets of the Company at their fair value at the 
inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding 
liability to the lessor is included in the consolidated statement of financial position as a finance lease 
obligation. Leases are initially recognised on the date from which the Company is entitled to exercise its 
right to use the leased asset, referred to as the commencement of the lease term, which corresponds to the 
date on which the equipment is received. Assets held under finance leases are depreciated over their 
expected useful lives on the same basis as owned assets or, where shorter, the term of the relevant lease. 

Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to 
achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised 
immediately in net income. Contingent rental payments are recognised as expenses in the periods in which 
they are incurred. 

Operating lease payments are recognised as an expense on a straight-line basis over the lease term, except 
where another systematic basis is more representative of the time pattern in which economic benefits from 
the leased asset are consumed. Contingent rental payments arising under operating leases are recognised as 
an expense in the period in which they are incurred. 

2.12 Intangible assets other than goodwill 

Customer relationships acquired in a business combination and recognised separately from goodwill are 
initially recognised at their fair value at the acquisition date, which is regarded as their cost. Subsequent to 
initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated 
amortisation and accumulated impairment losses. When intangible assets are purchased separately, as it was 
the case for patents, the cost comprises the purchase price and any directly attributable cost of preparing the 
asset for its intended use. When intangible assets are internally developed, as is the case with the Company’s 
internally developed patents, the cost comprises the directly attributable costs in the development phase 
necessary to create, produce and prepare the patent for the Company to be able to operate it for its intended 
use.  

An intangible asset is derecognised on disposal, or when no future economic benefits are expected from its 
use or disposal. Gains or losses arising from the derecognition of an intangible asset, measured as the 
difference between the net disposal proceeds and the carrying amount of the asset, are recognised in net 
income when the asset is derecognised. The amortisation of intangible assets, if any, is recognised in 
Administrative expenses in the consolidated statement of comprehensive income over the useful life of the 
intangible asset. Customer relationships are amortised on a straight-line basis over 8 years and patents are 
amortised as of the moment they can be used over the life of the patent (14 years). 

12 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.13 Impairment of property, plant and equipment and intangible assets other than goodwill 

At each reporting date, or sooner if there is an indication that an asset may be impaired, the Company 
reviews the carrying amounts of its property, plant and equipment and intangible assets, to determine 
whether there is any indication that they have suffered an impairment loss. If any such indication exists, the 
recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. 
When it is not possible to estimate the recoverable amount of an individual asset, the Company estimates the 
recoverable amount of the cash-generating unit to which the asset belongs. 

The recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in 
use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that 
reflects current market assessments of the time value of money and the risks specific to the asset for which 
the estimates of future cash flows have not been adjusted. 

If the recoverable amount of the assets is estimated to be less than their carrying amount, the carrying 
amount is reduced to the recoverable amount. An impairment loss is recognised immediately in net income. 

When an impairment loss subsequently reverses, the carrying amount of the assets is increased to the revised 
estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying 
amount that would have been determined had no impairment loss been recognised for the assets in prior 
years. A reversal of an impairment loss is recognised immediately in net income. 

2.14 Goodwill 

Goodwill arising on an acquisition of a business is carried at cost as established at the date of acquisition of 
the business less accumulated impairment losses, if any.  

For the purposes of impairment testing, goodwill is allocated to each of the Company's cash-generating units 
or group of cash-generating units that are expected to benefit from the synergies of the combination.  

A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or more 
frequently when there is indication that the unit may be impaired. If the recoverable amount of the cash-
generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying 
amount of any goodwill allocated to the unit and then to the other assets of the unit pro rata based on the 
carrying amount of each asset in the unit. Any impairment loss for goodwill is recognised directly in net 
income in the consolidated statement of comprehensive income. An impairment loss recognised for goodwill 
is not reversed in subsequent periods. 

2.15 Provisions 

Provisions are recognised when the Company has a present obligation, legal or constructive, as a result of a 
past event, it is probable that the Company will be required to settle the obligation, and a reliable estimate 
can be made of the amount of the obligation.  The amount recognised as a provision is the best estimate of 
the consideration required to settle the present obligation based on the most reliable evidence available at the 
reporting date, taking into account the risks and uncertainties surrounding the obligation. 

13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

2. Significant accounting policies (continued) 

2.16 Share-based compensation 

The Company uses equity-settled share-based compensation plans for its employees and consultants. None 
of the Company’s plans are cash-settled. Equity-settled share-based compensation is measured at the fair 
value of the services received at the grant date indirectly by reference to the fair value of the equity 
instruments granted, estimated using the Black-Scholes option pricing model. 

The fair value determined at the grant date of the equity-settled share-based compensation is expensed over 
the vesting period with a corresponding increase in Reserves. 

2.17 Share capital and reserves 

Share capital represents the amount received upon issuance of shares, net of transaction costs. Proceeds from 
the issuance of units consisting of shares and purchase warrants are allocated based on the relative fair 
values of each instrument. The fair value of the shares is based on the TSX share price at the time of the 
issuance and the fair value of the warrants is determined using a Black-Scholes valuation model. 

Reserves include the following: 

  Share-based compensation (see 2.16); 
  Accumulated foreign currency translation (see 2.4); 
  Warrants – comprises the value of outstanding and expired warrants; 
  Other (see Note 18). 

Upon the exercise of options and warrants, the proceeds received less the transaction costs are credited to 
share capital. 

3. Future accounting changes 

Certain new standards as well as amendments and improvements to existing standards have been published 
by the International Accounting Standards Board (“IASB”) but are not yet effective and have not been 
adopted early by the Company. Management anticipates that all of the relevant pronouncements will be 
adopted in the first reporting date following the date of application. The information on new standards as 
well as amendments and improvements to existing standards that may impact the Company’s consolidated 
financial statements are as follows: 

Revenue Recognition 

IFRS 15 – Revenue from Contracts with Customers was issued in May 2014 to replace IAS 18 – Revenue 
and IAS 11 – Construction Contracts as well as other revenue-related interpretations. The Company will 
adopt this new standard in the first quarter of 2018. IFRS 15 establishes a new control-based revenue 
recognition model based on the transfer of promised goods and services to customers at a point in time or 
over time, provides new and more detailed guidance on specific topics and provides additional requirements 
on the disclosures about revenue in the consolidated financial statements. Management is continuing to 
assess the impact of this new standard on its consolidated financial statements.  

14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

3. Future accounting changes (continued) 

Financial Instruments 

In July 2014, the IASB released IFRS 9 – Financial instruments, which will replace IAS 39 – Financial 
Instruments: Recognition and Measurement. This IFRS includes a revised model for the classification and 
measurement of financial assets and liabilities, a forward-looking ‘expected loss’ impairment model and a 
reformed approach to hedge-accounting. The Company will adopt this standard in the first quarter of 2018. 
Management is continuing to assess the impact of this new standard on the Company’s consolidated 
financial statements. 

Leases 

In January 2016, the IASB published IFRS 16 – Leases, which will replace the existing standard IAS 17 – 
Leases and related interpretations. This IFRS eliminates the classification as an operating lease and requires 
lessees to recognise a right-of-use asset and a lease liability in the statement of financial position for all 
leases with exemptions permitted for short-term leases and leases of low value assets. In addition, IFRS 16 
changes the definition of a lease, sets requirements on how to account for the asset and liability, including 
complexities such as non-lease elements, variable lease payments and options periods, changes the 
accounting for sale and leaseback arrangements, largely retains IAS 17’s approach to lessor accounting and 
introduces new disclosure requirements. IFRS 16 is effective for annual reporting periods beginning on or 
after January 1, 2019 with early application permitted in certain circumstances. The adoption of this new 
standard will require the Company to change the method used for accounting for operating leases, but 
management is continuing to assess the impact of this new standard on its consolidated financial statements. 

4. Critical accounting judgments and key sources of estimation uncertainty 

The preparation of these consolidated financial statements in conformity with IFRS and the application of 
the Company’s accounting policies described in note 2, required management to make judgments, estimates 
and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other 
sources. The estimates and associated assumptions are based on historical experience and other factors that 
are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting 
estimates are recognised in the period in which the estimate is revised if the revision affects only that period, 
or in the period of the revision and future periods if the revision affects both current and future periods. 

4.1 Critical judgments in applying accounting policies 

The following are the critical judgments, apart from those involving estimations, that management has made 
in the process of applying the Company's accounting policies and that have the most significant effect on the 
amounts recognised in the consolidated financial statements. 

Cash-generating units 

Management has identified only one cash-generating unit (“CGU”) for the Company. Revenue generated by 
the Company’s various product lines and facilities are generated through a single sales force whose ability to 
cross sell products influences the level of sale for each product line. Management has determined that the 
cash flows of the Company’s production facilities are closely interrelated and not independent. 

4.2 Key sources of estimation uncertainty 

The following are the key sources of estimation uncertainty at the end of the reporting period that have a 
significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the 
next financial year: 

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

4. Critical accounting judgments and key sources of estimation uncertainty (continued) 

Allowance for doubtful accounts 

The Company analyzes its trade receivables on an account by account basis and on a portfolio basis.  Any 
impairment recognised on these assets is based on historical experience and management’s best estimate of 
the recoverability of the account receivable. 

Useful lives of depreciable assets 

The Company reviews the estimated useful lives of property, plant and equipment and intangible assets other 
than goodwill at the end of each annual reporting period in order to ensure that the amortisation method used 
is appropriate. 

Impairment of long-lived assets 

If required, the Company performs impairment tests on its long-lived assets by comparing the carrying 
amount of the assets to their recoverable amount, which is calculated as the higher of the asset’s fair value 
less costs to sell and its value in use. Value in use is calculated based on a discounted cash flow analysis, 
which requires the use of estimates of future cash flow and discount rates. The Company uses judgment to 
determine whether it identifies any triggering event that may indicate that the long-lived assets have been 
impaired. 

Income taxes 

Management uses estimates in determining the appropriate rates and amounts in recording deferred income 
taxes, giving consideration to timing and probability of realization. Actual taxes could significantly vary 
from these estimates as a result of a variety of factors including future events, changes in income tax laws or 
the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the 
associated final taxes payable may result in adjustments to the Company’s deferred and current tax assets 
and liabilities. 

Warrants and share-based compensation 

The Company issues equity instruments from time to time, which are comprised of options to purchase 
common shares as well as common shares and warrants (units). The Company uses the Black-Scholes 
pricing model in order to determine the value of these instruments or how proceeds are allocated between the 
instruments. These methods require estimates based on market inputs. 

5. Segment information 

The  Company  operates  in  one  reportable  segment,  comprising  the  development,  manufacture  and  sale  of 
flexible packaging material in the form of film or bags, for various uses. 

5.1 Revenues by geographical end market 

The Company’s revenues by geographical end market are as follows: 

Canada  
United States 
Other 
Total 

Year ended 

December 31, 
2016

December 31, 
2015 

$ 27,387,025
45,954,583
171,816
$ 73,513,424

$ 25,724,900 
43,312,195 
113,535 
$ 69,150,630 

16 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

5. Segment information (continued) 

5.2 Property, plant and equipment and intangible assets per geographic location 

Canada  
United States 
Total 

December 31,
2016

December 31, 
2015 

$    6,889,509
13,381,376
$  20,270,885

$    6,707,965 
14,377,622 
$  21,085,587 

6. Additional information on the consolidated statements of comprehensive income 

The Company’s consolidated statement of comprehensive income includes depreciation of production 
equipment of $1,771,631 for the year ended December 31, 2016 ($1,412,442 in 2015) classified in Cost of 
sales. Depreciation of other property, plant and equipment and amortisation of intangible assets amounting 
to $229,274 for the year ended December 31, 2016 ($269,449 in 2015) is included in Administrative 
expenses. 

The Company’s consolidated statement of comprehensive income includes salaries paid to its employees of 
$8,952,979 for the year ended December 31, 2016 ($8,060,688 in 2015) classified in Cost of sales. 
Administrative expenses include salaries paid to employees of $1,569,759 for the year ended December 31, 
2016 ($1,460,906 in 2015) and Selling expenses include salaries paid to employees of $418,638 for the year 
ended December 31, 2015 ($629,437 in 2015). 

7. Employee benefits 

The Company contributes to state-run pension plans, employment insurance, group insurance and social 
security for its employees. The costs incurred for the employee benefits noted above amounted to 
$2,535,708 during the year ended December 31, 2016 ($2,302,252 in 2015). These payments are expensed 
as incurred and the Company does not recognise any gains or losses subsequent to the payment of these 
benefits. 

The Company also offers a defined contribution employee benefit plan to its employees located in North 
Carolina, USA. For the year ended December 31, 2016, the Company contributed $33,112 to this plan 
($28,151 in 2015). 

8. Finance costs 

Interest on bank indebtedness and long term debt  
Interest on obligations under finance leases 
Other interest 

Year ended 

December 31,  

2016

December 31, 
2015 

$   526,994
21,946
-

$   541,209 
24,966 
35,123 

$   548,940

$   601,298 

17 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

9. Income taxes 
9.1 Income tax recognised in net income 

Year ended 

December 31,  

2016

December 31, 
2015 

Income tax expense comprises: 
  Current tax expense 
  Deferred tax expense relating to the origination and 

reversal of temporary differences 

Total income tax expense 

$  583,107 

$  741,721 

5,900 
$  589,007 

(33,266) 
$  708,455 

9.2 Reconciliation between the income tax expense and the statutory income tax rate 

Income before income taxes 

Year ended 

December 31,  

2016

December 31, 
2015 

$ 997,074 

$ 1,521,673 

Income tax expense calculated at 26.9%  
Permanent differences 
Effect of unrecognised benefit of Imaflex USA’s 

losses 

Effect of different tax rates of subsidiaries operating in 

other jurisdictions 

Other 

268,213 
129,370 

409,330 
(24,390) 

499,205 

348,430 

(154,882)
(152,899)

(108,103) 
83,188 

Income tax expense recognised in net income 

$ 589,007 

$ 708,455 

The tax rate used for the 2015 and 2016 reconciliation above is the corporate tax rate of 26.9% payable by 
corporate entities in Quebec, Canada on taxable income under tax law in those jurisdictions. 

9.3  Deferred tax balances 

Opening 
balance

Recognised
in income

Adjustment 
to prior year 
balance

Closing 
balance 

2016 

Assets 

Non-capital losses 
Advance 
Inventory 
Other assets 

Liabilities 

$  3,325,043 
- 
234,899 
261,192 
3,821,134 

$  (903,040)
36,489 
(27,253)
12,029 
(881,775) 

$            - 
- 
- 
- 
- 

$  2,422,003 
36,489 
207,646 
273,221 
2,939,359 

Advance 
Property, plant and equipment 
Investment tax credits 

(87,926)
(5,016,111)
(2,690)
(5,106,727)  

87,926 
798,718 
(10,769) 
875,875 

Deferred tax liabilities 

$(1,285,593)   $     (5,900) 

$  

- 
- 
- 
- 

- 

- 
(4,217,393) 
(13,459) 
(4,230,852) 

$(1,291,493) 

18 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

9. Income taxes (continued) 

9.3  Deferred tax balances (continued) 

Opening 
balance

Recognised
in income

Adjustment 
to prior year 
balance

Closing 
balance 

$ 2,592,811 
245,222 
176,967 
3,015,000 

$   732,232 
(10,323)
84,225 
806,134 

$          - 
- 
               - 
               - 

$  3,325,043 
234,899 
261,192 
3,821,134 

2015 

Assets 

Non-capital losses 
Inventory 
Other assets 

Liabilities 

Advance 
Property, plant and equipment 
Investment tax credits 

(131,792) 
(4,196,687)

(5,380)  
(4,333,859)  

43,866 
(802,919)
2,690 
(756,363)  

- 
(16,505)
- 
(16,505)

(87,926) 
(5,016,111) 
(2,690) 
(5,106,727) 

Deferred tax liabilities 

$(1,318,859)  

$  49,771 

$ (16,505)

$(1,285,593) 

9.4 Unrecognised deferred tax assets 

The Company's subsidiary, Imaflex USA, has non-capital losses available to carry forward to reduce future 
taxable income of $25,975,542 in 2016 and $25,409,793 in 2015, for part of which a deferred tax asset has 
not been recognised ($7,708,458 in 2016 and $6,584,776 in 2015), that expire as follows: 

Expiring in 

December 31,  
2016 

December 31,  

2015

2025 
2026 
2027 
2028 
2029 
2030 
2031 
2032 
2033 
2034 
2035 
2036 

$       99,098 
1,837,014 
997,963 
2,324,783 
2,727,994 
4,531,532 
2,244,084 
3,108,650 
3,098,425 
2,738,496 
1,503,086 
764,417 
$25,975,542 

$       102,146 
1,893,518 
1,028,659 
2,396,291 
2,811,905 
4,670,917 
2,313,110 
3,204,269 
3,193,729 
2,822,729 
972,520 
- 
$25,409,793 

19 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

10. Earnings per share 

Year ended 

December 31, 
2016

December 31, 
2015 

Income for basic and diluted earnings per share 

$ 408,067

$ 813,218 

Weighted average number of common shares 

outstanding  

Dilutive effect of share purchase options 
Diluted weighted average common shares outstanding 

49,697,653
26,782
49,724,435

49,517,502 
75,915 
49,593,417 

Basic and diluted earnings per common share 

$   0.008

$   0.016 

An amount of 2,450,000 stock options outstanding as at December 31, 2016 were not included in the 
calculation of earnings per share because they were antidilutive (650,000 in 2015). 

11. Trade and other receivables 

Trade receivables  
Allowance for doubtful accounts 

Other receivables 
Total trade and other receivables 

Movement in the allowance for doubtful accounts 

December 31,
2016

December 31, 
2015 

$ 11,619,093 
(757,497)
10,861,596 

497,056 
$ 11,358,652 

$ 11,842,670 
(872,548) 
10,970,122 

531,340 
11,501,462 

Year ended 

December 31,
2016

December 31, 
2015 

Balance, beginning of year 
Release of allowance for doubtful accounts 
Account write-offs during the year 
Impairment losses recognised on trade receivables 
Foreign exchange 
Balance, end of year 

$ (872,548)
43,291 
325,535 
(264,502)
10,727 
$ (757,497)

$ (834,392) 
174,015 
- 
(154,015) 
(58,156) 
$ (872,548) 

Credit risk 
Credit risk is the risk that a counterparty fails to discharge an obligation to the Company. The Company’s 
maximum exposure to credit risk is limited to the carrying amount of the financial assets, net of any 
provisions for losses recorded on the Company’s consolidated statements of financial position. 

Credit risk management 
Credit risk associated with cash is mitigated by ensuring that these financial assets are primarily placed with 
major American and Canadian financial institutions that have been accorded grade ratings by a primary 
rating agency and qualify as creditworthy counterparties. The Company performs an ongoing review and 
evaluation of the possible risks associated with cash. 

20 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

11. Trade and other receivables (continued) 

For trade receivables, the Company uses an external credit service to assess the potential customer’s credit 
quality and uses this information to define the allowed credit limits by customer. Moreover, the Company 
uses credit insurance to mitigate credit risk. As at December 31, 2016, $5,448,146 ($4,099,851 as at 
December 31, 2015) of the total trade receivables are insured. The Company’s management considers that 
all receivables that are not impaired or past due for each reporting date are of good credit quality. 

Trade receivables past due but not impaired 
Trade receivables disclosed above include amounts that are past due at the end of the reporting period but 
not impaired, because the amounts are still considered recoverable based on the Company’s analysis of 
reimbursements. In situations where the Company believes there may be increased credit risk, netting 
agreements are signed in order to be able to settle any payables to the same customer on a net basis. At the 
end of the reporting period, there were $2,125,111 of past due trade receivables that were not impaired 
($2,220,105 in 2015). Of that amount, $564,318 was aged over 90 days ($796,676 as at December 31, 2015). 

Aging of total trade and other receivables 

Current 
31 days to 60 days 
61 days to 90 days 
Over 90 days 
Total 

12. Inventories 

Raw materials and supplies 
Finished goods 
Work in process 
Total 

Year ended 

December 31, 
2016

December 31, 
2015

$   5,515,051 
3,706,785 
1,560,793 
576,023 
$ 11,358,652 

$ 5,147,361 
3,750,836 
1,628,465 
974,800 
$ 11,501,462 

December 31,
2016

December 31, 
2015

  $  5,983,381
2,770,444
1,320,746
$ 10,074,571

$ 6,370,895
3,559,696
891,847
$ 10,822,438

The cost of inventories recognised as an expense during the year was $62,053,092 ($59,220,158 in 2015). 
There were no write-downs of inventory recognised in the fiscal year ended on December 31, 2016 or 2015. 

21 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

13. Property, plant and equipment 

Land 

Building 

Production 
equipment 

Leasehold 
improvements

Office 
equipment

Computer 
equipment 

  Equipment 

under 
finance lease 

Total 

Cost 

January 1, 2015 
Additions 
Foreign exchange 

December 31, 2015 
Additions 
Foreign exchange 

$ 

  $ 

- 
- 
- 

- 
- 
- 

  $ 42,217,660 
1,448,077 
3,191,245 

$ 1,929,506 
66,736 
134,006 

$ 43,298 
- 
3,124 

$ 420,296 
83,966 
2,599 

- 
22,649 
371 

- 
112,975 
1,852 

46,856,982 
1,193,306 
(594,068)

2,130,248 
113,286 
(26,513)

46,422 
- 
(576)

506,861 
5,030 
(1,163) 

$ 884,857 
- 
142,796 

1,027,653 
75,064 
(22,771)

$ 45,495,617 
1,598,779 
3,473,770 

50,568,166 
1,522,310 
(642,868)

December 31, 2016 

$ 23,020     

$ 114,827 

  $ 47,456,220 

$2,217,021 

$ 45,846 

$510,728 

$ 1,079,946 

$ 51,447,608 

Accumulated depreciation  

January 1, 2015 
Depreciation expense 
Foreign exchange 

December 31, 2015 
Depreciation expense 
Foreign exchange 

December 31, 2016 

Net book value, as at 

December 31, 2015 

- 
- 
- 

- 
- 
- 

- 

- 

- 
- 
- 

- 

(2,950)   
(73)   

(25,998,881)
(1,348,419)
(1,173,045)

(28,520,345)
(1,607,450)
219,062 

(1,498,058)
(179,365)
(87,280)

(1,764,703)
(219,594)
13,845 

(43,298)
-
(3,124)

(46,422)
- 
576 

(396,429) 
(21,856) 
(2,599) 

(420,884) 
(37,893) 
593 

(139,143)
(64,023)
(11,429)

(214,595)
(63,089)
2,022 

(28,075,809)
(1,613,663)
(1,277,477)

(30,966,949)
(1,930,976)
236,025 

$    (3,023)    $(29,908,733)

$ (1,970,452)

$ (45,846)

$(458,184) 

$ (275,662)

$(32,661,900)

December 31, 2016 

$ 23,020     

$ 111,804 

  $ 17,547,487 

$   246,569 

- 

  $ 18,336,637 

$   365,545 

  $  

  $  

- 

- 

$    85,977 

$ 813,058 

$ 19,601,217 

$    52,544 

 $ 804,284 

$ 18,785,708 

A portion of the Company’s production equipment with a carrying amount of approximately $17,700,000 
(approximately $16,000,000 as at December 31, 2015) is pledged as collateral for the Company’s long-term 
debt. 

14. Intangible assets 

Goodwill  

Customer 
relationships 

Patents 

Total 

January 1, 2015 
Additions 
Amortisation 
Foreign exchange 

December 31, 2015 
Additions 
Amortisation 
Foreign exchange 

  $   435,566 
- 
- 
84,065 

$  224,770 
- 
(48,006)
39,486 

  $     738,944 
29,767
(20,222)
- 

  $  1,399,280 
29,767 
(68,228) 
123,551 

519,631 
- 
- 
(15,507) 

216,250 
- 
(49,703)
(7,102)

748,489 
93,345 
(20,226)
- 

1,484,370 
93,345 
(69,929) 
(22,609) 

December 31, 2016 

$ 504,124 

$ 159,445 

  $   821,608 

$ 1,485,177 

22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

14. Intangible assets (continued) 

During the year ended December 31, 2014, the Company purchased the patents to ADVASEAL, a plastic 
film formulation for controlled release of plant protection products, including all the rights and intellectual 
property surrounding the co-extruded active ingredient-releasing agricultural film, which was co-developed 
by Imaflex. It also further invested in its existing patents in order to be able to obtain all required 
registrations. The patents for which EPA approval has not been obtained have not started being amortized in 
the years ended December 31, 2016 and 2015. 

December 31,
2016

December 31, 
2015 

$ 7,086,001
 1,663,000
$ 8,749,001

$ 7,617,334 
1,247,748 
$ 8,865,082 

15. Trade and other payables 

Trade payables 
Other payables and accrued liabilities 

16. Credit facilities 

Bank indebtedness (a) 

Long term debt 

Loan, bearing interest at the lender’s base rate (4.70% as at 
December 31, 2016 and 2015) minus 0.5% (plus 0.375% in 2015), 
refinanced during the year, secured by production equipment. (b) 

Loan (US$1,909,437, US$2,493,133 as at December 31, 2015), 
bearing interest at the US prime rate, reset monthly, plus 3.00% 
(effective rate of 6.75% as at December 31, 2016, 6.50% in 2015) 
secured by the production equipment of the subsidiary and a 
corporate guarantee from the Parent Company. (c) 

Total long term debt 

Finance leases (Note 17)  

Total borrowings 

Current 

Bank indebtedness 
Long-term debt, current portion 
Finance leases 

Non-current 

Long-term debt 
Finance leases 

Total borrowings 

December 31,
2016

December 31, 
2015

$  5,052,270

$  6,925,713

2,920,000  

2,208,751

2,563,801

5,483,801

3,450,157

5,658,908

392,714

487,606

10,928,785

13,072,227

5,052,270
1,355,760
170,740
6,578,770

4,128,041
221,974
4,350,015

6,925,713
1,358,488
153,959
8,438,160

4,300,420
333,647
4,634,067

$ 10,928,785

$ 13,072,227

23 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

16. Credit facilities (continued) 

Interest on long-term debt amounted to $297,356 for the year ended December 31, 2016 ($347,379 in 2015). 

(a)  The Company has an operating line of credit with its bankers to a maximum of $10,000,000, bearing 

interest at prime plus 0.90% (3.60% effective interest rate at December 31, 2016, 3.85% as at 
December 31, 2015).  The line of credit is secured by trade receivables and inventories. The line of 
credit may be reviewed periodically by the bank and is repayable on demand. The operating line of 
credit is subject to working capital, debt to equity and minimum EBITDA covenants (as defined in the 
lending agreement). As at December 31, 2016, the Company had drawn $5,052,270 ($6,925,713 as at 
December 31, 2015) on the line of credit. 

(b)  During the year ended December 31, 2016, the Company refinanced a loan obtaining $961,510 of 

additional funds in order to replenish working capital. The loan is repayable in one instalment of 
$40,950 followed by monthly instalments of $40,550 until November 2022. Following the refinancing, 
the interest applicable to the loan decreased from 0.375% over the lender’s base rate to 0.50% under the 
lender’s base rate (effective rate of 4.20% as of December 31, 2016 and 5.075% as at December 31, 
2015). 

(c)  This loan is repayable in 20 equal quarterly instalments through January 2020 and bears interest at a rate 
of 3.00% over the US prime rate for an effective rate of 6.75% as at December 31, 2016 (6.50% as at 
December 31, 2015). This loan was recorded at the effective interest rate method, net of all incremental 
transaction costs directly attributable to the transaction. During the year ended December 31 2015, the 
Company drew an additional amount of $587,023 (USD $463,580) on this facility. This loan is subject 
to certain covenants. As at December 31, 2015, the Company was not in compliance with its Interest-
bearing-debt-to-EBITDA and fixed-charge-coverage ratio covenants. However, the Company obtained 
waivers as at December 31, 2015 confirming tolerance for these breaches for a period of more than one 
year. As at December 31, 2016, the Company was in compliance with all covenants related to this loan. 

The aggregate scheduled repayment of long term debt is as follows : 

Not later than one year 
Later than one year and not later than five years 
Later than 5 years 

$ 1,345,162 
3,711,516 
446,050 
$ 5,502,728 

17.  Obligations under finance leases 

The Company has entered into certain finance lease agreements. Finance lease payments are due as follows : 

Not later than one year 
Later than one year and not later than five years 
Later than five years 
Total minimum lease payments 
Less amount representing interest at approximately 6.1% 
Present value of minimum lease payments 
Less the long term portion 
Current portion of obligations under finance leases 

$  185,452 
230,942 
- 
416,394 
(23,680)
392,714 
(221,974)
170,740 

During the year ended December 31, 2016, the Company financed the acquisition of production equipment 
of a value totalling $75,064 by entering into a finance lease for the entire amount of the purchase. 

24 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

18. Share capital 

The Company’s authorized share capital consists of an unlimited number of common shares, voting, 
participating, without par value. At December 31, 2016, there were 49,738,637 common shares outstanding 
(49,638,637 common shares at December 31, 2015). 

During the year ended December 31, 2015, the Company issued 1,381,695 shares following the exercise of 
warrants that entitled the holders to purchase shares of the Company at $0.45 per share for total proceeds of 
$621,762, of which $296,053 had been received during the year ended December 31, 2014 in anticipation 
for the exercise of these warrants. These warrants were issued as part of a private placement that closed on 
February 1, 2012. The amount of $296,053 that was received during the year ended December 31, 2014 was 
reclassed from Other items within Reserves to Share Capital and an amount of $185,147 was reclassed from 
Warrants within Reserves to Share Capital. The impact of this transaction on shareholder’s equity is as 
follows : 

Proceeds received in 2014 
Proceeds received in 2015 
Value of warrants reclassed from 
Warrants to Share capital 

Share 
capital 
296,053  $
325,709 
185,147 

Warrants 

-  $
- 
(185,147)

Total 
296,053  $ 
325,709 
- 

806,909  $

(185,147) $

621,762  $ 

During the year ended December 31, 2015, 2,824,363 warrants entitling the owners to acquire one additional 
common share of the Company expired. As at December 31, 2015, there were no warrants outstanding. 

19. Share-based compensation 

Pursuant to the Stock Option Plan (the “Plan”) of the Company, 3,735,000 of the common shares are 
reserved for options. The Plan provides that the term of the options shall be fixed by directors. Officers and 
employees of the Company are eligible to receive options. Options are granted at an exercise price of not 
less than the fair value of the Company’s shares on the date the options are granted. Options may be 
exercisable for a period no longer than five (5) years and the exercise price must be paid in full upon 
exercise of the option. 

During the year ended December 31, 2016, the Company granted 1,300,000 options to an employee and two 
consultants to acquire common shares at $0.40 for a period of five years. These options vest in 4 tranches 
over 2 years, the first vesting six months after issuance and the other tranches vesting at six-month intervals. 
Reserves were increased by $142,080 representing the share-based compensation related to this issuance for 
the year ended December 31, 2016. 

During the year ended December 31, 2016, the Company granted 500,000 options to an employee to acquire 
common shares at $0.42 for a period of five years. These options vest in 4 tranches over 18 months, the first 
vesting immediately at issuance and the remaining tranches vesting at six-month intervals. Reserves were 
increased by $56,691 representing the share-based compensation related to this issuance for the year ended 
December 31, 2016. 

During the year ended December 31, 2015, the Company issued 650,000 options to employees and one 
consultant to acquire shares at $0.52 for a period of 5 years. These options vest in 4 tranches over 2 years, 
the first vesting six months after issuance and the other tranches vest at 6-month intervals. Reserves were 
increased by an amount of $82,525 during the year ended December 31, 2016 ($102,641 in 2015), 
representing the share-based compensation for the periods. 

25 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

19. Share-based compensation (continued) 

The following are the assumptions used in order to value the options as well as general information on each 
outstanding option grant: 

Fair value assumptions 

06/09/2016  21/06/2016 16/06/2015 15/07/2013 15/01/2013  27/05/2011

Total

Outstanding as at 01/01/2015 
Issued 
Expired 
Outstanding as at 31/12/2015 
Exercised 
Issued 
Outstanding as at 31/12/2016 
Exercisable as at 31/12/2015 
Exercisable as at 31/12/2016 
Remaining life of options (yrs) 
Expected life of options (yrs) 
Expiry 

Expected share price volatility 
Dividend yield 
Risk free rate 

-
650,000
-
650,000
-
-
650,000
162,500
487,500
3.46

- 
- 
- 
- 
- 
500,000 
500,000 
- 
125,000 
4.69 

100,000 
- 
(100,000)
- 
- 
- 
- 
- 
- 
- 

100,000 
- 
(100,000) 
- 
- 
- 
- 
- 
- 
- 
2.75 to 3.5 0.99 to 1.37 0.99 to 1.37 

-
-
-
-
-
1,300,000
1,300,000
-
325,000 
4.48
2.5 to 3.25  2.75 to 3.5
06/09/2021  21/06/2021 15/06/2020 15/07/2015
106.54% -
125.9%
0% 
1.27% 

100,000 
- 
- 
100,000 
(100,000)
- 
- 
100,000 
- 
- 
2.5 
15/01/2015  27/05/2016 

134.8% - 
191.1 % 
0% 
1.18% 

172.86% 
0% 
1.67%

76.59% - 
79.60% 
0% 
0.51% 

75.95% -
82.15%
0%
0.50%

300,000 
650,000 
(200,000)
750,000 
(100,000)
1,800,000 
2,450,000 
262,500 
937,500 

Exercise price 
Share price on grant date 
Fair value of option at grant 

$ 0.42 
$ 0.42 
$ 0.21 

$ 0.40
$ 0.40
$ 0.21

$ 0.40 
$ 0.40 
$ 0.19 

$ 0.36 
$ 0.32 
$ 0.20 

$0.125 
$0.125 
$0.100 

83.19% -
98.85%
0%
0.55% to 
0.65%
$ 0.52
$ 0.52
$ 0.30

The expected volatility was calculated using the average closing price change of the Company’s shares on 
the TSX over the expected life of the options. 

20. Non-cash transactions 

During the year ended December 31, 2016, the Company financed the acquisition of production equipment 
of a value totalling $75,064 by entering into a finance lease for the entire amount of the purchase. Additional 
information on finance leases is provided in note 17. 

26 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

21. Financial instruments 

21.1 Fair value and classification of financial instruments 

Carrying amount and fair value
December 31, 
December 31,
2015
2016

$      68,100
10,873,302
10,941,402

$      160,975
11,148,246
11,309,221

5,052,270
7,804,787
5,483,801
18,340,858

6,925,713
8,272,779
5,658,908
20,857,400

392,714

487,606

Financial assets 
Loans and receivables 

Cash 
Trade and other receivables (1)  

Financial liabilities 
Financial liabilities, at amortised cost 

Bank indebtedness 
Trade and other payables (2) 
Long term debt 

Other liabilities 

Finance lease obligations 

(1) Excludes sales taxes 
(2) Excludes employee benefits 

Fair value estimates are made as of the date of the consolidated statement of financial position, using 
available information about the financial instrument. These estimates are subjective in nature and often 
cannot be determined with precision. 

The following methods and assumptions were used to determine the estimated fair value of each class of 
financial instruments: 

  The fair value of cash, trade and other receivables, bank indebtedness and trade and other payables 
approximates their respective carrying amounts as at the date of the consolidated statement of 
financial position because of the short-term maturity of those instruments. 

  The fair value of long-term debts and finance lease obligations, which mainly bear interest at 

floating rates, is estimated using a discounted cash flows approach, which discounts the contractual 
cash flows using discount rates derived from observable market interest rates of similar loans with 
similar risks. 

The Company ensures, to the extent possible, that its valuation techniques and assumptions incorporate all 
factors that market participants would consider in setting a price and that it is consistent with accepted 
economic methods for pricing financial instruments. 

27 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

21. Financial instruments (continued) 

21.2 Fair value hierarchy 

The Company categorizes its financial instruments into a three-level fair value measurement hierarchy as 
follows: 

Level–1 - valuation based on quoted prices (unadjusted) in active markets for identical assets or liabilities; 

Level–2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are 
observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); 

Level–3 - valuation techniques using inputs for the asset or liability that are not based on observable market 
data (unobservable inputs). 

As at December 31, 2016 and 2015, the fair values of long-term debt and finance lease obligations are 
categorised as Level 2. 

22. Operating lease arrangements 

22.1 Leasing arrangements 

The Company leases its premises for manufacturing locations from related parties under operating leases.  
Rent is paid monthly and there are no restrictions imposed on the Company under these leasing 
arrangements.  There is no contingent rent under those leasing agreements and no sublease payments 
received by the Company.  The leases expire at various dates to August 2020, and include renewal 
provisions. 

22.2 Payments recognised as an expense 

Lease payments for premises 
Vehicles 
Office equipment 

22.3 Non-cancellable operating lease commitments 

Not later than 1 year 
Later than 1 year and not later than 5 years 
Later than 5 years 

Year ended 

December 31, 
2016

December 31,  
2015 

  $   934,845 
35,004 
17,032 

  $   944,277 
34,248 
8,406 

Year ended 

December 31, 
2016

December 31, 
2015 

  $  

931,274 
3,206,060 
1,873,205 
  $  6,010,539 

  $   797,161 
2,610,569 
1,154,879 
  $ 4,562,609 

28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

23. Risk management 

23.1 Capital management 

The Company’s objective in managing capital is to ensure sufficient liquidity to pursue its growth while at 
the same time taking a conservative approach towards financial leverage and financial risk.  

The Company’s capital is composed of net debt and shareholders’ equity. Net debt consists of interest-
bearing debt less cash. The Company’s primary uses of capital are to finance increases in non-cash working 
capital and capital expenditures for capacity expansion and integration. 

The Company’s primary measure to monitor financial leverage is Debt to Earnings before Interest, Taxes, 
Depreciation and Amortization (“EBITDA”). 

Credit facility arrangements require that the Company meet certain financial ratios at fixed points in time. 
The financial covenants are, as at December 31, 2016: 
- Working capital ratio, defined as current assets divided by current liabilities greater than or equal to 

1.10:1.00; 

- Debt to equity ratio, defined as total debt excluding taxes divided by equity and deferred taxes less 

intangible assets of less than or equal to 2.50:1.00; 

-  Interest bearing debt divided by EBITDA ratio (as defined) less than or equal to 4.00:1.00; 
- Fixed charge coverage ratio calculated on a yearly basis equal to or greater than 1.10:1.00; 
- To maintain a minimum EBITDA (as defined) of $1,900,000 for the fiscal year ended December 31, 2016. 

23.2 Foreign currency risk management 

The Company’s Canadian operations face foreign currency risk as a result of a significant portion of the 
costs of raw material for these sales being in USD. The Company’s sales in USD act as a hedge against this 
risk, mitigating the risk.  

The Company also faces foreign currency risk through its foreign subsidiary, Imaflex USA, whose 
functional currency is the USD. Imaflex does not specifically hedge this foreign currency risk. 

The Company also has a portion of its long term debt in USD. The majority of the cash flows generated by 
the assets financed by these borrowings in USD are in USD.  

The following is the Company’s financial assets and liabilities denominated in USD, which is in a currency 
other than the Company’s functional currency: 

Cash 
Trade receivables 
Trade payables  
Bank indebtedness 
Gross financial position exposure 

$  

December 31,
2016
369 
2,279,387 
(3,903,091)
(1,173,716)
$ (2,797,051)

  $  

December 31, 
2015
5,964 
3,671,530 
(4,170,709)
(2,244,011)
$ (2,737,226)

29 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

23. Risk management (continued) 

23.2 Foreign currency risk management (continued) 

A 5% appreciation of the Canadian dollar against the USD would impact its financial position by $244,616 
as at December 31, 2016 (December 31, 2015 - $354,784 ).  Conversely a 5% depreciation of the Canadian 
dollar against the USD would have the opposite effect. Management estimates that every $0.01 appreciation 
of the USD against the Canadian dollar would have a negative impact on the Company’s result of 
approximately $30,000. Every $0.01 depreciation of the USD against the Canadian dollar would have the 
opposite effect. 

23.3 Interest rate risk management 

The Company’s exposure to interest rate fluctuations is with respect to its short-term and long-term 
financing, which bear interest at floating rates. 

At the reporting date, the carrying value of the Company’s interest-bearing financial liabilities was as 
follows: 

Variable rate instruments 
Financial liabilities  

Gross financial position exposure 

Sensitivity analysis 

December 31,
2016

December 31, 
2015

$ 10,536,071
$ 10,536,071

$ 12,584,621
$ 12,584,621

A 100 basis point increase in interest rates at the reporting date would result in a decrease in income for the 
year ended December 31, 2017 of approximately $92,739 ($118,952 for 2016 as at December 31, 2015). 
Conversely a decrease would have the opposite effect. 

23.4 Liquidity risk management 

Liquidity risk, the risk that the Company will not be able to meet its financial obligations as they fall due, is 
managed through the Company’s capital structure and financial leverage. The Company obtains financing 
through a mix of share issuance on the capital markets and borrowings from financial institutions. An 
analysis of financial leverage is used to determine the required mix between the different sources of liquidity 
offered to the Company while keeping an acceptable risk level in the Company’s leverage. 

The Company ensures that it maintains sufficient cash flow to pay its obligations within the next 12 months. 
Cash flows generated from operations are matched to the liquidity required to meet its financial obligations 
for the sources of financing used to generate that cash flow. 

The Company has an operating line of credit of up to $10,000,000, of which an amount of $5,052,270 was 
utilized as at December 31, 2016. Borrowings under the Company’s operating line of credit bear interest at 
the bank’s prime rate plus 0.90%. In order to ensure that this line of credit is sufficient to fund the 
Company’s cash requirements, management follows the movements in the collateral against which the line 
of credit is given. 

30 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

23. Risk management (continued) 

23.4 Liquidity risk management (continued) 

As at December 31, 2016, the carrying amount and undiscounted contractual cash flows for the Company's 
liabilities are as follows: 

Carrying 
amount 

Contractual 
cash flow 

1 year or less 

2-5 years  More than 5 

Bank indebtedness 
Long term debt 
Interest on borrowings (1) 
Finance leases (2) 
Trade and other payables 

$ 5,052,270
5,450,684
33,117
392,714
7,804,787

$ 5,052,270   $ 5,052,270
1,312,046 
253,463 
185,452 
7,804,787 

5,469,611
630,652
416,394
7,804,787

$                  - 
3,711,515 
367,792 
230,942 
- 

years 

$             -
446,050
9,397
-
-

$18,733,572

$19,373,714

$14,608,018

$ 4,310,249 

  $  455,447

(1)  The interest on the long term debt is based on prevailing interest rates at the date of the consolidated 
statement of financial position. 
(2)  The contractual cash flow for finance leases includes the interest on the borrowings. 

24. Related party transactions 

Entities in which key management personnel has an interest 

During the year, in the normal course of business, the Company had routine transactions with entities owned 
by shareholders and key management personnel of the Company. These transactions are measured at fair 
value, which is the amount of consideration established and agreed to by the related parties. Details of these 
transactions not disclosed elsewhere in these consolidated financial statements are as follows: 

Entities owned by key 

management personnel or their 
family members 

Rent 
Key management personnel services 
Entities over which key 

management personnel have 
significant influence 

Professional services 

Transactions for the year 
ended 

Amounts owing as at 

Non-secured commitments 
as at 

December 31, 
2016

December 31, 
2015

December 31, 
2016

December 31, 
2015 

December 31, 
2016

December 31, 
2015

$     877,693
145,909

$     825,461   $  
138,017

- 
12,257 

$              -   $ 5,947,770 
- 

12,273 

$ 4,480,279
- 

138,269

82,914

138,269 

82,914 

- 

- 

$  1,161,871

$  1,046,392   $  150,526   

$  95,187 

$ 5,947,770 

$ 4,480,279

31 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the consolidated financial statements 
for the years ended December 31, 2016 and 2015 

24. Related party transactions (continued) 

Key management personnel 

The table below details the compensation paid to the key members of management, which include the 
Company’s chief executive officer, the vice president of marketing and innovation, the production director, 
the vice president of corporate affairs, the corporate controller and members of the board of directors. 

Salaries 
Director’s fees 
Short-term employee benefits 
Post-employment benefits – State-run plans 
Share-based compensation 
Other benefits 

Year ended 

December 31, 
2016
$ 685,485
44,750
8,883
18,267
178,679
38,682
$ 974,746

December 31, 
2015
$ 653,053
40,250
3,830
13,104
15,791
33,273
$ 759,301

32